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Reactive oxygen species (ROS), including hydroxy! radical (OH), hydrogen 
peroxide (H202), superoxide (02") and peroxyl radicals are produced during normal 
aerobic metabolism as well as many pathologic conditions, such as tissue ischemia, 
degenerative and inflammatory diseases. These reactive species are also induced 
by ionizing radiation and many carcinogenic chemicals and can cause DNA damage, 
including single strand breakage and base modifications. Among these radicals, 
superoxide anion radical is the most abundant species generated in vivo by several 
enzymatic and non-enzymatic pathways in mammalian tissue and has been 
implicated in several disease states and alteration of biomolecules. 
Riboflavin (vitamin B2) is present in free and conjugated form in tissues and 
exists as coenzyme FAD and FMN which are photosensitizers. Photosensitized 
riboflavin generates reactive oxygen species ( '02 , 02") via oxygen dependent 
photodynamic action, by binding covalently to DNA and poly(dA).poly(dT) and 
is responsible for DNA strand breaks. 
ROS are well known to be cytotoxic and have been implicated in the etiology 
of many human diseases including cancer. Various carcinogens exert their effect 
by generating ROS during their metabolism. Oxidative damage to cellular DNA 
can lead to mutations and may, therefore, play an important role in carcinogenesis 
and other biological processes. Increased levels of modified bases in cancerous 
cells may be due to the large amounts of H,02, abnormal levels of antioxidant 
enzymes (SOD or catalase). Monitoring DNA damage, induced specifically by 
superoxide anion radicals, has been the strategy used in this study. 
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease of 
unknown etiology characterized by the presence of autoantibodies in circulation 
that bind to numerous self antigens such as DNA, RNA, ribonucleoproteins, 
phospholipids and histones. Although antibodies that react with B-conformation 
are found in sera of patients with SLE, B-DNA per ser is a poor immunogen. 
On the other hand, various other conformations of DNA such as right handed 
A-form and left handed Z-form are potentially immunogenic. Also, DNA modified 
with ROS, certain chemicals, in conjugation with the female sex hormone-estradiol 
i i 
and photocrosslinked with 8-methoxypsoralen have been found to result in the 
production of antibodies. It has been reported that ROS modification of dsDNA 
results in an increased binding of anti-DNA antibodies from SLE sera. Thus, it 
could be suggested that a conformational variant of B-form is essential for the 
generation of anti-DNA antibodies. 
In the present study, commercially available purified calf thymus DNA was 
modified by superoxide anion radicals generated by riboflavin on exposure to 
flourescent light leading to single strand breaks and base modifications. The 
superoxide induced modifications in DNA were analyzed by UV and CD 
spectroscopic techniques. The modified DNA showed hyperchromicity at 260 nm, 
as compared to native DNA, thereby, reflecting the presence of single stranded 
regions in the modified DNA. The Tm of 0 2 "-DNA was found to be 82.5°C, 
whereas, native DNA showed a T of 87°C. A net decrease of 4.5°C in the T 
value of O, -DNA indicates a partial destruction of its secondary structure. The 
single strand breaks induced in DNA as a result of modification by 02*' were 
detected by hydroxyapatite column chromatography, alkaline sucrose density 
gradient ultracentrifugation and nuclease S, sensitivity assay. Superoxide radical 
was found to induce base modification, which was quantified by ion exchange 
chromatography on DEAE Sephadex A-25 column. The results indicated the 
modification of thymine to a greater extent (51.8%) followed by guanine (40.5%) 
and adenine (22.2%). 
The antigenicity of superoxide radical modified DNA was probed by inducing 
antibodies in rabbits. The repertoire of specificities of induced antibodies were 
evaluated by direct binding and competition ELISA. The induced antibodies 
exhibited polyspecificity, a property commonly associated with SLE anti-DNA 
autoantibodies. Anti-02"-DNA antibodies showed preferential binding to ROS-
modified forms of synthetic nucleic acid polymers. 
In the present work, twelve SLE sera from patients having high titre anti-
DNA autoantibodies were studied for their binding to native and O '-DNA. 
Specificity of antigenic determinants on DNA was assessed by inhibition ELISA. 
i n 
In direct binding assay, each antibody bound 0 2 '-DNA in preference to dsDNA. 
This preference was confirmed by inhibition ELISA. The binding specificity of 
native and 0 2 '-DNA with SLE anti-DNA autoantibodies was further analyzed by 
gel retardation assay. Immunofluorescence of the kidney sections of rats immunized 
with native and 02"-DNA showed the deposition of immune complex in the 
glomeruli as detected by apple green fluorescence. The immune complex deposition 
may cause kidney inflammation and tissue destruction. This could be correlated 
to acute stage of lupus nephritis, wherein, deposition of immune complexes has 
been considered to elucidate inflammatory reaction. 
The quantitative precipitin reaction results indicated high specificity of SLE 
anti-DNA autoantibodies for 0 2 '-DNA. The affinity constants of SLE IgG for 
native and 02"'-modified DNA was l.lxlO~TM and and 2.7xl0~8 M respectively. 
These results demonstrate that anti-DNA antibodies can be induced by 02"mediated 
DNA damage and that some of autoimmune DNA binding antibodies found in SLE 
may result from responses to such modified DNA. 
Similarly, cancer sera were screened for the presence of antibodies reactive 
with native and 0 2 '-DNA. Four sera from breast cancer showed higher recognition 
of 0 2 "-DNA than native DNA, while one sera showed moderate but higher 
recognition with 02"-DNA. Three sera from cancer of urinary bladder showed 
higher reactivity with 0 2 -DNA, whereas, out of five sera from cancer of gall 
bladder, only one showed 50% inhibition with modified DNA and with native DNA 
all five sera showed inhibition below 50%. Among three sera of lung cancer, 
having a history of smoking, two sera showed higher inhibition of 62% and 69% 
with 0 2 '-DNA. One serum each from Hodgkin's lymphoma, renal cell and prostate 
cancer showed high reactivity with 02"'-DNA, whereas, one serum from caecum 
carcinoma had higher recognition for nDNA (37%) as compared to 02""-DNA 
(32%). Sera from stomach and rectal cancers showed almost negligible inhibition 
with native and 02 ' -DNA. 
In conclusion, the superoxide radical causes damage to DNA and renders it 
highly immunogenic. The antibodies against modified DNA are polyspecific in 
i v 
nature resembling the antigen binding characteristics of SLE anti-DNA 
autoantibodies. It is postulated that superoxide modified DNA may play a major 
role in the production of SLE anti-DNA autoantibodies and circulating antibodies 
in cancer. 
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Reactive oxygen species (ROS), including hydroxyl radical (OH), hydrogen 
peroxide (H202), superoxide (O z ' ) and peroxyl radicals are produced during normal 
aerobic metabolism as well as many pathologic conditions, such as tissue ischemia, 
degenerative and inflammatory diseases. These reactive species are also induced 
by ionizing radiation and many carcinogenic chemicals and can cause DNA damage, 
including single strand breakage and base modifications. Among these radicals, 
superoxide anion radical is the most abundant species generated in vivo by several 
enzymatic and non-enzymatic pathways in mammalian tissue and has been 
implicated in several disease states and alteration of biomolecules. 
Riboflavin (vitamin B2) is present in free and conjugated form in tissues and 
exists as coenzyme FAD and FMN which are photosensitizers. Photosensitized 
riboflavin generates reactive oxygen species ( '02 , 02~") via oxygen dependent 
photodynamic action, by binding covalently to DNA and poly(dA).poly(dT) and 
is responsible for DNA strand breaks. 
ROS are well known to be cytotoxic and have been implicated in the etiology 
of many human diseases including cancer. Various carcinogens exert their effect 
by generating ROS during their metabolism. Oxidative damage to cellular DNA 
can lead to mutations and may, therefore, play an important role in carcinogenesis 
and other biological processes. Increased levels of modified bases in cancerous 
cells may be due to the large amounts of H,02, abnormal levels of antioxidant 
enzymes (SOD or catalase). Monitoring DNA damage, induced specifically by 
superoxide anion radicals, has been the strategy used in this study. 
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease of 
unknown etiology characterized by the presence of autoantibodies in circulation 
that bind to numerous self antigens such as DNA, RNA, ribonucleoproteins, 
phospholipids and histones. Although antibodies that react with B-conformation 
are found in sera of patients with SLE, B-DNA per ser is a poor immunogen. 
On the other hand, various other conformations of DNA such as right handed 
A-form and left handed Z-form are potentially immunogenic. Also, DNA modified 
with ROS, certain chemicals, in conjugation with the female sex hormone-estradiol 
i i 
and photocrosslinked with 8-methoxypsoralen have been found to result in the 
production of antibodies. It has been reported that ROS modification of dsDNA 
results in an increased binding of anti-DNA antibodies from SLE sera. Thus, it 
could be suggested that a conformational variant of B-form is essential for the 
generation of anti-DNA antibodies. 
In the present study, commercially available purified calf thymus DNA was 
modified by superoxide anion radicals generated by riboflavin on exposure to 
flourescent light leading to single strand breaks and base modifications. The 
superoxide induced modifications in DNA were analyzed by UV and CD 
spectroscopic techniques. The modified DNA showed hyperchromicity at 260 nm, 
as compared to native DNA, thereby, reflecting the presence of single stranded 
regions in the modified DNA. The T of O "'-DNA was found to be 82.5°C, 
o m 2 
whereas, native DNA showed a T of 87°C. A net decrease of 4.5°C in the T 
value of 02*-DNA indicates a partial destruction of its secondary structure. The 
single strand breaks induced in DNA as a result of modification by 0 2 ' were 
detected by hydroxyapatite column chromatography, alkaline sucrose density 
gradient ultracentrifugation and nuclease S, sensitivity assay. Superoxide radical 
was found to induce base modification, which was quantified by ion exchange 
chromatography on DEAE Sephadex A-25 column. The results indicated the 
modification of thymine to a greater extent (51.8%) followed by guanine (40.5%) 
and adenine (22.2%). 
The antigenicity of superoxide radical modified DNA was probed by inducing 
antibodies in rabbits. The repertoire of specificities of induced antibodies were 
evaluated by direct binding and competition ELISA. The induced antibodies 
exhibited polyspecificity, a property commonly associated with SLE anti-DNA 
autoantibodies. Anti-02 -DNA antibodies showed preferential binding to ROS-
modified forms of synthetic nucleic acid polymers. 
In the present work, twelve SLE sera from patients having high titre anti-
DNA autoantibodies were studied for their binding to native and O/'-DNA. 
Specificity of antigenic determinants on DNA was assessed by inhibition ELISA. 
I l l 
In direct binding assay, each antibody bound 02"*-DNA in preference to dsDNA. 
This preference was confirmed by inhibition ELISA. The binding specificity of 
native and 02 -DNA with SLE anti-DNA autoantibodies was further analyzed by 
gel retardation assay. Immunofluorescence of the kidney sections of rats immunized 
with native and 0 2 -DNA showed the deposition of immune complex in the 
glomeruli as detected by apple green fluorescence. The immune complex deposition 
may cause kidney inflammation and tissue destruction. This could be correlated 
to acute stage of lupus nephritis, wherein, deposition of immune complexes has 
been considered to elucidate inflammatory reaction. 
The quantitative precipitin reaction results indicated high specificity of SLE 
anti-DNA autoantibodies for 0 2 -DNA. The affinity constants of SLE IgG for 
native and 02"'-modified DNA was l.lxlO"TM and and 2 .7x l0 8 M respectively. 
These results demonstrate that anti-DNA antibodies can be induced by 02 'mediated 
DNA damage and that some of autoimmune DNA binding antibodies found in SLE 
may result from responses to such modified DNA. 
Similarly, cancer sera were screened for the presence of antibodies reactive 
with native and 0,"'-DNA. Four sera from breast cancer showed higher recognition 
of 02 '-DNA than native DNA, while one sera showed moderate but higher 
recognition with 0 2 ' -DNA. Three sera from cancer of urinary bladder showed 
higher reactivity with 02~'-DNA, whereas, out of five sera from cancer of gall 
bladder, only one showed 50% inhibition with modified DNA and with native DNA 
all five sera showed inhibition below 50%. Among three sera of lung cancer, 
having a history of smoking, two sera showed higher inhibition of 62% and 69% 
with 02"-DNA. One serum each from Hodgkin's lymphoma, renal cell and prostate 
cancer showed high reactivity with 02"-DNA, whereas, one serum from caecum 
carcinoma had higher recognition for nDNA (37%) as compared to 0 2 *-DNA 
(32%). Sera from stomach and rectal cancers showed almost negligible inhibition 
with native and O., '-DNA. 
In conclusion, the superoxide radical causes damage to DNA and renders it 
highly immunogenic. The antibodies against modified DNA are polyspecific in 
i v 
nature resembling the antigen binding characteristics of SLE anti-DNA 
autoantibodies. It is postulated that superoxide modified DNA may play a major 
role in the production of SLE anti-DNA autoantibodies and circulating antibodies 
in cancer. 
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The familiar right-handed helical form of DNA was first described by 
Watson and Crick in 1953. In a fully hydrated medium, DNA is found in, 
what is called the B-form (Langridge et al., 1960) and is the most accepted 
structure of DNA molecule in solution. A number of variations in 
conformation of this basic s t ructure have been described (Adams et al., 
1981) and are in equilibrium with each other (Rich et al., 1984; Pechenaya, 
1993). The major physical evidence for the structure of DNA comes from 
X-ray diffraction studies of fibres (Langridge et al., 1960). The importance 
of DNA lies in its unique proper ty to adopt mult iple conformations 
depending on its b ioenvironment . Under the influence of super helical 
tension, appropriate sequence signals may cause the formation of left 
handed Z-DNA, so called because phosphate groups in the backbone are 
zigzagged (Rich et al., 1984), cruciform (Lilley, 1980), dehydrated form 
A-type DNA in growing cells (Set low, 1992) and tr iple-stranded structures 
(Mirkin et al, 1987; Htun and Dalberg, 1989). The DNA double helix is 
both deformed and made deformable by its local base sequence , whereas, 
other regions may be made especially susceptible to a change in 
conformation when the helix in teracts with neighbours-a protein molecule, 
drug molecule, or an adjacent DNA helix in crystal la t t ice . Thus DNA has 
been shown to be a molecule with a high degree of f lexibil i ty, whose 
structure depends on interact ion with other molecules (Travers , 1989). 
Antigenicity of DNA 
The antigenicity of nucleic acids has received considerable attention, 
since the first report of ant i -DNA antibodies in sera of pat ients with 
systemic lupus erythematosus (SLE) in 1957 and identified DNA as the 
reactant of these antibodies (Cepel l in i et al., 1957). In the early 1960s, 
methods were developed for the experimental induction of ant ibodies to 
nucleic acids (Levine et al., 1960; Erlanger and Beiser, 1964; Plescia et 
al., 1964; Halloran and Parker, 1966) which until then had been considered 
widely to be non-immunogenic. Exogenous native B-DNA has not been 
2 
immunogenic in experimental animals. Immunization of experimental animals 
with denatured DNA, synthet ic polynucleotides like poly (dT), poly (dC), 
poly (A), poly (I), poly (G) , double stranded RNA, left handed Z-DNA, 
chemically modified DNA and certain helical synthetic polynucleotides have 
induced immune responses (Stollar, 1986; Anderson et al., 1988). An 
important property of the resu l t ing antibodies is that they do not crossreact 
with native DNA. 
The DNA molecule has several unique features which have a direct 
bearing on its immune reac t ions . First, it appears in nature in different 
helical forms including both r ight handed (A- and B-DNA) and left handed 
(Z-DNA) helix (Setlow, 1992) . The second feature of DNA antigen which 
dis t inguishes the m o l e c u l e from most p ro t e in an t igens is its 
multideterminant nature. The third feature and perhaps , its most intriguing 
one, is its polyanionic na ture . The double helical DNA has a hydrophobic 
core of stacked heterocyclic bases and a soluble sugar-phosphate backbone 
with highly acidic phosphate residues. The phosphate res idues make DNA 
a notoriously sticky ant igen. The polyanionic nature of the DNA antigen 
has a direct effect on the c l inical assay of anti-DNA ant ibodies . Many serum 
proteins are capable of b inding to DNA under physiological conditions 
(Eilat, 1986). 
The reversal in handedness of double s tranded helical DNA 
accompanying B- to Z- t ransi t ion is one of the most dramat ic examples of 
DNA polymorphism (Pie t rasanta et al., 1994). Increased salt concentrations 
induced change in aqueous solution of poly (dG-dC) . Poly (dG-dC) to 
produce a new DNA conformation (Pohl and Jovin, 1972). In both the non-
metal ion and the metal ion assisted radiation induced conformation 
changes, the conversion is from the right handed B-DNA to the left handed 
Z-DNA conformation. These changes are discussed in terms of the potential 
significance of the Z-conformation in the control of the DNA transcription 
process (Trumbore et al., 1994). A-like DNA is character ized by more base 
3 
pairs per turn of the helix and a wider minor groove than B-like DNA. 
A-like DNA is generally formed under conditions of low water content and 
is usually not associated with the living system (Saenger, 1984). There is 
significant evidence that the conformation of poly(dG).poly(dC) in solution 
is A-like (Sarma et al., 1986) . It has been reviewed recent ly that DNA 
in dormant spores of Bacillus species is induced in A-like conformation, 
and that A-like DNA can also form in growing cells (Set low, 1992). 
The biologically important B-form of DNA is better adapted to fine 
recognition processes, as it t rans la tes and amplifies sequence information 
more effectively into a large conformational variation. Since, A-DNA is 
known to have only one s table conformation for each base sequence, their 
backbones are much less var iab le than B-DNA (Poncin et al., 1992). The 
conformational substates de tec ted in B-DNA are conserved under 
deformation and it is important to note that the relative s tabi l i ty of different 
substates can easily be changed by overwinding or underwinding which is 
an interesting possibility for biologically controlled mechanisms . The 
structural differences and mul t ip l i c i ty of conformational substa tes found for 
B-DNA, have a minor inf luence on the energetics or mechanism of 
deformation of the double hel ix (Poncin et al., 1992). 
Attempts have been made to immunize animals with DNA of thymus 
but without a substantial immune response. Similar resul ts were also 
obtained on the injection of purified native or denatured salmon, calf 
thymus, phage T4 or E. coli DNA (Plescia et al., 1964; Levine and Stollar, 
1968). A low degree of cross react ivi ty of DNA from various sources was 
seen, especially the finding that antisera induced by calf thymus DNA did 
not react with beef spleen or o ther mammalian DNA. Injection of denatured 
DNA (Lamber t and D i x o n , 1968) , or of the d o u b l e hel ical 
polyribonucleotides, po ly ( I ) .po ly (C) (Carpenter et al., 1970) in to NZB/ 
NZW mice accelerated the spontaneous production of an t ibodies to DNA 
and double stranded RNA. As free bacteriophage, native or denatured DNA 
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was not immunogenic (Levine and van Vunakis, 1967), it appears that a 
DNA-protein complex was the effective immunogen. 
Immunization of animals with nucleic acid-MBSA complexes resulted 
in antibodies that reacted with free denatured DNA, but not with B-
conformation of DNA. They also showed cross-reactivity with denatured 
DNA from widely different species . Left handed Z-DNA is an example of 
a helical DNA that is much more potent immunogen than native B helical 
DNA (Madaio et al., 1984). The antibodies induced by Z-DNA have a high 
degree of selectivity, as they react with immunogen, but not with B-DNA 
or ssDNA (Zarling et al., 1984). Most of the antibodies induced by modified 
DNA do not react with the unmodified DNA (Anderson et al., 1988a). 
In complex with MBSA, several polynucleotides including poly(A), poly(I), 
and poly(C), that differ from the B-helical DNA conformation, are much 
stronger immunogen than nat ive B-DNA (Braun and Lee, 1988). 
Immunization of rabbits with MBSA complex of right handed poly (dG-dC). 
poly (dG-dC) induced ant ibodies specific for polymer, but did not react with 
native E. coli DNA or native denatured calf thymus DNA. 
There is compelling evidence that bacterial DNA, in contrast to 
mammalian DNA, induces a variety of responses in both normal humans and 
animals (Pisetsky, 1996). Ant ibodies to bacterial DNA in normal human sera 
are predominantly IgG2, whereas , lupus anti-DNA ant ibodies are mainly 
IgGl and IgG3. Animals following immunization with bacterial DNA induce 
antibodies showing negl ig ible cross-reactivity with mammalian DNA 
(Gilkeson et al., 1991). Recent ly , it has been found that sera from normal 
human subjects showed binding to highly purified bacter ial dsDNA. It has 
been postulated that bacterial DNA can induce antibody product ion during 
infection because of sequences rarely present in host DNA and, therefore, 
recognized as foreign (Pise tsky et al., 1990). 
Injection of his tone-DNA complexes yielded some ant i -h is tone but not 
anti-DNA antibodies (StolJar and Ward, 1970), nor did immunizat ion with 
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isolated nuc leosomes induce anti-DNA responses (Einck et al., 1982). 
Ant ibodies have also been generated against chemically modified and 
triple hel ical DNA. Immunization with methylated BSA complexes of 
modified DNA, as with cisplatin modified DNA (Poirier, 1981; Sundquist 
et al., 1987) or with modified nucleosides or nucleotides conjugated to 
proteins has led to the induction of ant ibodies (Muller and Rajewsky, 1980). 
A triple hel ical DNA can be formed at neutral pH by a mixture of poly(dT-
dm5C) and poly(dG-dA) (Lee et al., 1980). Monoclonal antibodies generated 
against this complex polymer, recognized the antigen, but failed to react 
with other re la ted polynucleotides that can not form a triple helix (Lee et 
al., 1987). 
It has been reported from our laboratory that immunization of reactive 
oxygen species modified DNA induces ant ibodies , exhibit polyspecificity 
(Ara and Al i , 1992; 1993; Alam et al., 1993) and recognizes B, A and allied 
conformations of DNA (Ara and Ali, 1995). Monoclonal antibodies against 
ROS-DNA have also been generated to be used as an immunochemical probe 
to detect ox ida t ive DNA lesions in cancer, ageing and SLE (Ahmad et al., 
1998; Ashok et al., 1997). The female sex hormone (estradiol) in 
conjugation with DNA produced non-precipi ta t ing antibodies (Moinuddin 
and Ali, 1994). The photocrosslink between DNA and 8-methoxypsoralen 
(8-MOP) was observed to be highly immunogenic , inducing high titre 
antibodies (Arif and Ali, 1996). 
Oxygen Free Radicals 
Free radicals are chemical species possess ing an unpaired electron 
(Haliiwell and Gutteridge, 1989) that can be considered as fragment of 
molecules and are generally very react ive . They can be posit ively or 
negatively charged or electrically neutral . Free radicals can be formed in 
three ways : 
6 
(i) By the homolytic cleavage of covalent bond of a normal molecule, with 
each fragment retaining one of the paired electrons (von Sonntag, 
1987) . 
(ii) Loss of single electron from a molecule. 
(iii) By the addition of a single electron to a normal molecule. The electron 
transfer is a more common process in biological systems than 
homolyt ic fission: 
Radical formation by electron transfer: A + e" -> A" 
Radical formation by homolytic fission: X : Y -> X" -+• Y" 
Radical formation by heterolytic fission: X : Y -> X + Y + 
Free radicals are generated in vivo by oxidant enzymes, phagocytic 
ce l l s , r edox-cyc l ing drugs, ioniz ing rad ia t ion , etc. (Hall iwel l and 
G u t t e r i d g e , 1989). These radicals cause damage to a number of 
macromolecules including lipids and proteins (Lunec et al., 1985; Wolff et 
al., 1986; Lunec, 1990). However, the most susceptible macromolecule is 
DNA (Runger et al., 1995) and thus may form a basis for mutagenesis and/ 
or c a r c i n o g e n e s i s (Breimer, 1990; Breen and Murphy, 1995) . In 
consequence , organisms have evolved not only antioxidant defense systems 
to p ro tec t against them, but also repair systems that prevent the 
accumulat ion of oxidatively damaged molecules (Halliwell and Gutter idge, 
1989; Sies, 1991). 
The term reactive oxygen species (ROS) is a collective one that 
includes not only oxygen-centered radicals such as superoxide (O "') and 
hydroxyl ("OH), but also some non-radical derivative of oxygen, such as 
hydrogen peroxide (H202), singlet oxygen ( ' 0 2 ) , hypochlorous acid (HOC1) 
and ozone ( 0 3 ) . ROS are highly reactive and have extremely short half l ives. 
This react iv i ty is due to the unstable electronic configuration of the 
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radicals . They readily extract e lect rons from other molecules with which 
they coll ide and this in turn becomes a free radical and thus highly reactive. 
It has been proposed that many of the damaging effects could be attributed 
to chemically reactive species like superoxide (02")> hydrogen peroxide and 
hydroxyl radical ('OH) (Halliwell, 1987; Halliwell and Gutter idge, 1989). 
Hydrogen peroxide is ubiquitous in biological systems, formed by the 
divalent reduction of dioxygen or by dismutation of the superoxide anion 
radicals ( 0 2 ' ) catalyzed by superoxide dismutase (SOD) (Tachon, 1989). 
2 0 2 ' + 2H* > H 2 0 2 + 0 2 
Normal cellular levels of hydrogen peroxide is in the range of 10 8 -
10"9M (Oshino et al., 1973). It can be elevated as a result of inflammation, 
where the respiratory burst of phagocyt ic cells occur (Hammers and Roos, 
1985). As a low molecular weight and uncharged species, H 2 0 2 can diffuse 
readily from the site of production and traverse cell membranes (Frimer 
et al., 1983). 
Much of the toxicity of free radica ls in vivo is thought to result from 
reaction of OH, which can be produced in cells by metal ion dependent 
conversion of superoxide (02"') and hydrogen peroxide or by interact ion of 
ionizing radiation with cellular water (von Sonntag, 1987). Homolyt ic 
fission of 0 - 0 bond in hydrogen peroxide by heat or ionizing radiat ion 
produces two 'OH. A simple mixture of H 2 0 2 and iron (II) salt also forms 
the OH radical, as was first observed by Fenton in 1894. 
Fe+2 + H 2 0 2 > Fe+3 + ~0H + 'OH 
and the second, by the interact ion of superoxide anion with H O 
through the Haber-Weiss reaction (Haber and Weiss, 1934). 
0 2 - + H 2 0 2 > Q2 + H20 + 'OH 
8 
Superoxide Anion Radicals (02*) 
One electron reduction of oxygen leads to the formation of superoxide 
anion radical (Florence, 1990; Harr i s , 1992). This radical is formed in all 
aerobic organisms and sys tems generating 0 2 * have been observed to kill 
bacteria , inactivate viruses, damage enzymes, membrane and destroy animal 
cells in culture (Fridovich, 1978; Halliwell, 1981). Exogenous chemical 
sources of 0 2 " that can convenient ly be used to assess the genotoxic 
potential of oxygen metabol i te include 
(i) xanthine oxidase act ing aerobically on xanthine or hypoxanthine, 
which produces a s teady flux of superoxide radical 
(ii) potassium superoxide ( K 0 2 ) , which dissolves in water with the 
liberation of the superoxide anion radical 
These two systems, which are actually used to assay superoxide 
dismutase enzyme activity, are clean sources of 0 2 ' , in the sense that this 
species is primarily the only act ivated form of oxygen that is generated. 
However, H202 is also immedia te ly formed by spontaneous or catalyzed 
dismutation of 02". 
Both exogenous sources of 02"* have been shown to be genotoxic, 
which is attributed to its abi l i ty to damage chromosomal DNA (Emerit et 
al., 1982). Interestingly, chromosomal breakage was observed in several 
autoimmune diseases such as lupus erythematosus, rheumatoid arthri t is and 
ulcerative colitis (Emerit, 1986) . Therefore, it is possible that superoxide 
radical produced in excessive amount might be responsible for DNA damage 
in autoimmune diseases. The current ly persisting dominant view of O ' 
toxicity is that it damages cel ls only indirectly, by giving r ise to hydroxyl 
radical (Halliwell and Gut te r idge , 1992). However, the seminal work of 
Fr idovich (1986) has demons t r a t ed that 0 2 " itself can exert direct 
deleterious effects in b io logica l systems. A number of enzymatic targets of 
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superoxide have been identif ied. For example, in vitro inactivation of 
r ibonucleot ide r educ ta se , the key enzyme prov id ing the 
deoxyribonucleotides required for DNA synthesis is lethal for any organism 
(Gaudu, 1996). Protein R2, the small component of the enzyme, containing 
an iron centre and an essential tyrosyl radical is converted into an inactive 
form lacking the radical during the reaction with 02"' (Larsson, 1986). 
Since superoxide dismutase (SOD) is specific for superoxide anion 
radical as substrate, it follows that 0 2 ' must be a toxic species . Indeed, 
0 2 ' generating systems have many damaging effects, several of which are 
summarized in Table 1. 
Superoxide chemistry differs greatly depending on whether reactions 
are carried out in aqueous solution or in organic solvent . The most 
important feature of 0 2 ' is its ability to act as Bronsted base, which, 
in aqueous media, shifts the acid-base equilibrium towards the formation 
of hydroperoxyl radical . In polar environments, 02"' is a powerful base, 
nucleophile and reducing agent (Sawyer and Valentine, 1981; Frimer, 1982). 
Superoxide radical can reduce many metal cations by electron transfer. 
Fe+3 + O," > Fe+2 + 0 2 
Analogous reactions occur with other cations ( M n + \ Cu+2), chelated 
iron and many enzymes (Valent ine, 1979; Weser et al., 1981). Several 
scientists (Winterbourn, 1979; 1981; Fee, 1982) have argued that this can 
not occur in vivo because the concentration of other biological reducing 
agents would be greater than that of 0 2 ' . 
Sources of Superoxide in injured tissues 
(a) Xanthine oxidase 
Xanthine oxidase has been proposed to be an important source of 
oxygen derived free radicals in reperfused tissue (Granger et al.,1981; 
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TABLE-1 
Some Deleterious Effects of Systems Generating the Superoxide 
Radical* 
Source of 0, System studied Damage Comments 
Heart muscle sub-
mitochondrial particles 
Illuminated FMN 
Xanthine + xanthine 
oxidase 
Xanthine + xanthine 
oxidase 
Illuminated FMN 
Illuminated FMN 
Activity of NADH-CoQ 
reductase complex 
Bacteria 
Human synovial fluid 
Bacteriophage R17 
Ribonuclease 
Calf myoblast cells 
Hypoxanthine + xanthine Rat brain membrane 
Activity lost Damage prevented by SOD. The 0 / 
generated by the complex inacti-
vatesit unless SOD is present. 
Catalase not protective. 
Loss of viability Protection by SOD 
Degradation; Both SOD and catalase protect 
loss of viscosity 
lnactivation SOD protects partially 
Loss of activity SOD protects partially 
Growth c n n » ' " • • ' " -of.-oii-. 
abnormality, 
some cell death 
lnactivation 
SOD protects partially
SOD protects partially 
oxidase 
Acetaldehyde + xanthine 
oxidase 
Acetaldehyde + xanthine 
oxidase 
Hypoxanthine + xanthine 
oxidase 
Hypoxanthine + xanthine 
oxidase 
Xanthine + xanthine 
oxidase 
Xanthine + xanthine 
oxidase 
Xanthine + xanthine 
oxidase 
Xanthine + xanthine 
oxidase 
Xanthine + xanthine 
oxidase 
(Na-,K.-)-ATPase 
Erythrocyte membranes 
Arachidonic acid 
DNA 
Cheek pouch of living 
hamster (perfused with 
superoxide generating 
system) 
Rat lung in vivo 
(instilled in to 
lungs) 
Rat heart ornithine 
decarboxylase 
Rat heart mitochondria 
Rat heart or liver 
mitochondria 
Dog heart sarcoplasmic 
reticulum 
Lysis 
Oxidation 
Degradation, 
single strand 
breaks, attack 
on sugar moiety-
Increased 
permeability of 
blood vessels, 
leakage of 
contents 
Acute lung 
injury, oedema 
lnactivation 
Lowered P/0 
ratios and lower 
SOD 
Both 
protects 
SOD and catalase protects 
SOD.'OH scavengers and catalase 
protect. Iron salt needed. 
SOD 
SOD 
SOD 
COH 
SOD 
respiratory control 
inhibiton of 
net Ca2' uptake 
Decreased Ca:" 
uptake 
protects 
protects but not catalase 
protects, also mannitol 
scavenger) 
and catalase protects 
Protects SOD or mannitol 
('OH 
Some 
mann 
scavenger) 
protection by SOD and 
itol 
*F rom Hal l iwe l l and G u t t e r i d g e ( 1 9 8 4 ) 
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Chambers et al., 1985; McCord et al., 1985; Hearse et al., 1986). Nascent 
xanthine oxidase exists as a dehydrogenase using NAD' as electron acceptor 
during the oxidation of hypoxanthine and xanthine (Battelli et al., 1972). 
Studies in the intestine suggested that ischemia promotes the conversion 
of xanthine dehydrogenase to xanthine oxidase, such that after a short 
period of ischemia virtually all of the enzyme is in the oxidase form, which 
now uses molecular oxygen as its acceptor, producing superoxide and 
hydrogen peroxide (Parks and Granger , 1986). Ischemia causes the 
degradation of ATP into hypoxanthine, a substrate for xanthine oxidase. 
(b) Mitochondria 
The production of superoxide by the mitochondria has been known 
for nearly two decades (Boveris et al., 1976; Turrens and Boveris, 1980). 
The rate of superoxide production by the mitochondria increases when the 
concentrat ion of oxygen is increased or the respiratory chain becomes 
largely reduced (Turrens et al., 1982). Mitochondria produce superoxide 
anion at two sites in the electron transport chain. The first site is the 
ubiquinone to cytochrome C, step, which passes through the intermediate 
ubisemiquinone (Boveris et al., 1976; Cadenas et al., 1977; Turrens et 
al., 1985). The second site of superoxide anion formation is the NADH 
d e h y d r o g e n a s e (Turrens and Bove r i s , 1980). Several s tudies have 
demonstrated that mitochondria become uncoupled upon tissue ischemia 
(Jennings and Ganote, 1976; Watanabe et al., 1985; Piper, 1989). 
(c) Neutrophils 
The activated NADPH oxidase of phagocytic cells is a potentially large 
and significant source of free radicals in stimulated neutrophils. After 
init iat ion of the respiratory burst, more than 90% of the consumed oxygen 
can be accounted for by the generat ion of superoxide. Production of 
O,"' and H : 0 2 by neutrophils is enhanced after the cells adhere to surfaces 
or after they are primed with a chemical stimulus (Dahinden et al., 1983). 
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Hernandez et al. (1987) have demonstrated an important role for 
neutrophi ls in ischemia/reperfusion induced microvascular intestinal injury. 
Using anti-neutrophil serum and MO-1 antibody (which prevent neutrophil 
adhesion) , these investigators showed a near complete at tenuation of 
microvascular permeability caused by ischemia and reperfusion of the small 
intest ine. The fact that oxygen radical scavengers and allopurinol also 
provide a complete extent of protection to that of neutrophil depletion led 
these invest igators to suggest that xanthine oxidase - derived reactive 
oxygen metaboli tes play an important role in eliciting neutrophil infil tration. 
(d) Catecholamines 
The autooxidation of catecholamines has been proposed to cause 
myocardial damage during ischemia and reperfusion (Singal et al., 1982; 
Murrel l et al., 1990). Jewett et al. (1989) reviewed the role of 
catecholamine autooxidation in ischemia/reperfusion and suggested that 
this process is extremely low or non-existent at physiological pH and, 
therefore, unlikely to be a primary source of oxygen radicals in pathological 
states. They also suggested that the oxidation of catecholamines observed 
in superoxide anion generated by substrate dependent processes, enzyme-
catalyzed peroxidative processes and possibly trace metal cata lys is . 
Biological Effects of the Superoxide Radicals 
The superoxide radical is generated within aerobic biological systems 
during both enzymatic and non-enzymatic oxidation. It is e l iminated by 
conversion to H202 and 0 2 by superoxide dismutase (Fridovich, 1983; 1986). 
They are induced by oxygen exposure of anaerobes (Privalle and Gregory, 
1979), increasing intracellular production of 02"' at constant pO, , through 
the recycl ing of quinones and related compounds (Moody and Hassan, 
1982). 
Bovine liver catalase was inactivated by 02"" and H,0 2 produced by the 
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aerobic xanthine oxidase reaction and this was completely prevented by 
SOD (Rister and Baehner, 1976). Inact ivat ion of catalase by 0 2 * is biphasic , 
with a rapid phase being followed by a much slower phase (Kono and 
Fridovich, 1982). The rapid phase could be, both, prevented and reversed 
by SOD, whereas, the slow phase was prevented by SOD but not reversed. 
Several instances of a correlation between increased 0 2 ' and decreased 
glutathione peroxidase have been reported. Exposure of guinea pig to 
hyperoxia, which would increase product ion of superoxide radical resulted 
in compensatory increase in SOD, but a concomitant decrease in both 
catalase and glutathione peroxidase (Rister and Baehner, 1976). 
Hemorrhagic shock is associated with an increase in plasma iron 
(Mazur et al., 1955). While invest igat ing the basis of this effect, Green 
and Mazur (1957) observed that anaerobic incubation of slices of l iver and 
other t issues as well, resulted in the accumulation of hypoxanthine and 
xanthine. They found that xanthine oxidase while acting upon its substrates , 
mobil ized iron from ferritin and that this iron release was augmented under 
100% 0 2 and was not prevented by catalase. This iron release may be an 
important aspect of reperfusion injury. Reperfusion injury is the damage 
imposed by temporary interruption of blood flow to a tissue. 
Numerous studies of the effects of an 0 2 ' flux upon erythrocytes have 
been reported. l ,4-napthoquinone-2-sulfonate reacts with oxyhemoglobin 
yielding methemoglobin plus O, " and can be used to increase O, ' product ion 
in erythrocytes (Goldberg and Stern, 1976). 
Since neutrophils congregate in response to chemotactic s ignals , upon 
act ivat ion, they exhibit a large increase in consumption of dioxygen and 
produce large amounts of superoxide radical . These radicals would readily 
enter the adjacent erythrocytes via the anion channels and then react with 
oxyhemoglobin. 
Several studies have implicated both 0 2 * and H202 in the lung damage 
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caused by hyperoxia. There is one report in which 0 2 " was clearly shown 
to exert an effect, independent of H 2 O r Thus, Johnson et al. (1981) 
inst i l led enzymatic sources, as well as scavengers, of 0 2 ' and of H 2 0 : , 
d irect ly in to the airways of rat lung. Damage to the lung was measured 
in terms of accumulation of l 2 5I-labelled albumin. Xanthine oxidase plus 
xanthine , used as a source of 0 2 * and H 2 0 : , caused damage which was 
prevented by SOD, but not by cata lase . 
A small number of molecules do react with 0 2 *. Some of these such 
as epinephrine (McCord and Fr idovich , 1969), bilirubin (Robertson and 
Fr idovich, 1982), biliverdin (Gall iani et al., 1984), a - tocopherol , and 
water-soluble analogues thereof (Ozawa, 1985) are clearly biologically 
relevant . 
Transfer of glycoaldehyde moiety from keto-sugar to aldo-sugar is an 
important pathway of glucose metabol ism, Glycoaldehyde being transferred 
is carried by the enzyme in the form of an a, P-dihydroxyethylthiamine 
pyrophosphate intermediate. It appears that this intermediate can be 
oxidized by 02". 
When isolated transketolase, plus fructose 6-phosphate, was exposed 
to superoxide radical generated by the xanthine oxidase reaction or added 
as K 0 2 dissolved in DMSO, glycolate was produced and SOD prevented 
its production, but catalase did not (Takabe et al., 1980). 
Biochemical Role of Riboflavin 
Riboflavin commonly known as vitamin B2 is present both in free and 
conjugated forms (Spector, 1961) in nature and in tissue for serving as an 
essential nutrient of the physiological system. The best source of riboflavin 
is yeast . Although fruits and vegetables are moderately good sources of 
this vitamin, they are not consumed in sufficient quantities to meet the daily 
requirements . Rapidly growing green leafy vegetables are a particularly 
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good source. 
Riboflavin consists of the sugar alcohol D-ribitol a t tached to 7,8-
dimethylisoalloxazine. It is relat ively heat stable but sensitive to irreversible 
decomposition upon exposure to visible light. Lumichrome and lumiflavin 
are the photodegradation products of riboflavin. 
Riboflavin may exist in the nuclear material, possibly as coenzymes 
such as flavin adenine dinucleot ide (FAD) or flavin mononucleot ide (FMN) 
which are also photosensi t izers (Dahl and Richardson, 1978) . FMN is 
formed by the ATP dependent phosphorylation of riboflavin, whereas , FAD 
is formed by the transfer of an AMP moiety from another ATP molecule 
to FMN. The FMN and FAD serve as prosthetic groups of oxidation-
reduction enzymes. ( F i g . 1 ) 
Photosensitized riboflavin is known to bind covalently to DNA and 
to poly(dA). poly(dT) (Ennever and Speck, 1983) and is responsible for 
DNA strand breaks (Speck and Rosenkranz, 1975). Ribof lavin is 
photoexcited by light to its triplet state. Photoexcited r ibof lavin would 
then be fully reduced in the chemical process. Spontaneous reoxidation of 
photoreduced riboflavin by molecular oxygen would result in the formation 
of superoxide radical (Dahl and Richardson, 1980). There are definitive 
evidence to support that photosensitized riboflavin genera tes reactive 
oxygen species ( '0 2 , 0 2 " etc) via oxygen dependent pho todynamic action 
(Joshi, 1985). 
Riboflavin is a potent photosensi t izer which generates s ingle t oxygen 
and superoxide anion radical when exposed to ultraviolet l ight of 290-400 
nm. This results in photodegradat ion of ascorbic acid in mi lk (Allen and 
Parks, 1979), carotenoids, vi tamin B6 and folic acid in human p lasma (Roe, 
1987) and single strand breaks in intracellular DNA in human cell culture 
(Ennever and Speck, 1983). Riboflavin also has some photochemica l action 
on quercetin (Takahama, 1985), phenylalanine (Ishimitsu et al., 1985) and 
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flavin adenine dinucleotide. 
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tryptophan (Bhat ia and Rassin, 1985). 
Some genet ic defects of blood cell r iboflavin enzymes have been 
reported. For example , the neut rophi l s of pat ients with chronic 
granulomatous disease lack an FAD-containing enzyme necessary to form 
superoxide radica l (Babior and Kipnes, 1977). 
DNA Damage and its Repair 
DNA damage may be defined as any modification of DNA resulting 
in altered or impaired replication and t ranscr ipt ion. Lesions producing 
major dis tor t ion of the DNA helix are more likely to interfere with functions 
essential for maintenance of cellular integrity and thus may lead to gross 
disturbance and death (Harris, 1983). 
Oxygen free radicals (OFR) are generated both physiologically and 
pathological ly in mammals inducing many kinds of cellular damage (Floyd, 
1990; Ames et al., 1993a) including DNA damage, interfering directly with 
cell s ignal l ing and growth (Cerutti et al., 1992; 1994). Oxidative damage 
to DNA inc ludes a range of specifically oxidized purines and pyrimidines 
as well as a lkal i labile sites and strand breaks (Dizdaroglu, 1994; Breen 
and Murphy, 1995). The apparently most studied oxidative lesion in DNA 
involves C-8 hydroxylation of guanine. 
Among potent ia l markers of DNA damage, 8-hydroxyguanosine (8-
OHdG), is a typical form of oxidative lesion (Dizdaroglu, 1991) having 
potential to cause mutation (Wood et al., 1990; Shibutani et al., 1991). 
The 8-OHdG level in human urine has been reported to be correlated with 
smoking s ta tus (Loft et al., 1992), although urinary 8-OHdG may be derived 
not only from DNA but also from free nucleotides (Maki and 
Sekiguchi ,1992). 
Reduct ion of DNA can also lead to the ring opening product 2,6-
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d iamino-4-hydroxy-5- fo rmamidopyr imid ine (Dizdaroglu, 1991). Other 
abundant oxidatively modified purines and pyrimidines include 7,8-dihydro-
8-oxoadenine (8-oxo-dA), 2 -hyd roxyaden ine , Fapyadenine, 5-
hydroxymethyluracil , 5-hydroxycytosine, cytosine glycol and thymine glycol. 
In addition, a large number of other modificat ion of bases and sugars have 
been identified (Dizdaroglu, 1991; 1994; Kamiya et al., 1995). 
Mi tochondr ia l DNA (mtDNA) has been found to be especial ly 
vulnerable to attack by oxygen free radicals (Driggers et al., 1996), since 
this organelle consumes approximately. 90% of the body oxygen and 1-
2% of this is converted to superoxide radical (Richter, 1992). Oxidative 
damage to cellular DNA can be mutagenic and may, therefore, play an 
impor tant role in tumorigenesis . It has been shown that 8-
hydroxydeoxyguanos ine is mu tagen ic , causing GC—>AT base pair 
subst i tut ions (Kuchino et al., 1987) and can result in activation of the 
human C-Ha-ras-1 gene (Kamiya et al., 1992). 
The most striking evidence implicat ing 02"' in the production of DNA 
damage in vivo has been obtained with E. coli strains lacking cytosolic 
SOD. These strains are hypermutagenic when grown in air-saturated media, 
suggesting that an increase in 0 2 " leads to an increase in DNA damage (Farr 
et al., 1986). Furthermore, the manganese-containing SOD (MnSOD) 
isozyme and endonuclease, an o x i d a t i v e DNA repair enzyme, are 
coregulated by the SoxRS regulon (Chan and Weiss, 1987; Greenberg et 
al., 1990), which implies that oxidative repair enzymes as well as SOD must 
be induced to protect the cell from oxidat ive stress by O -. These in vivo 
observations seem to support the prevai l ing hypothesis for the role of O, 
in the induction of DNA damage. 
DNA damage by the xanthine-xanthine oxidase system in a metal free 
solution is due to 0 2" . SOD, a specific inhibitor of 0 2" , and not the boi led 
enzymes, almotttctmoletely inhibits DNA damage and the scavenger o f - O H , 
mannitol does not have any significant effect. The above fact clearly 
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established that 0 2 ' is truly capable of inducing strand breaks (Sah et al., 
1995). 
DNA repair is an immediate response after DNA damage and several 
repair pathways are likely to be elicited when cells are exposed to oxygen 
species (Sage , 1993). The nucleotide excision repair system of E. coli 
UvrABC, however, is not pivotal for handl ing oxidative damage in contrast 
to its crucial role in the repair of s t ructural ly distorting lesions, such as 
pyrimidine photodimers and some carcinogenic adducts (Sancar and Tang, 
1993). Unrepaired DNA or inaccurate repair of damage can lead to cell 
death (Jackson, 1996). 
In vivo oxidative DNA damage is repaired continuously by a variety 
of enzymes . Strand breaks are annealed and modified bases are excised as 
such or as nucleotides (Ramotar and Demple , 1993; Demple and Harrison, 
1994). DNA glycosylases excise bases and subsequently phosphodiester 
bonds on each site of the abasic site are incised by endonucleases allowing 
the inser t ion of an intact nucleotide. Some enzymes such as endonuclease 
III possess both glycosylase and endonuclease activities for repair of 
oxidized pyr imidines . The repair p roduc ts of this excision, include 
thymidine , thymine glycol (Tg) and hydroxyuraci l which are excreted into 
the ur ine. The formamidopyrimidine-DNA glycosylase enzyme (Fpg; mutM) 
in E. coli repairs the oxidized pur ines 8-oxoguanine and 2,6-diamino-4-
hydroxy-5-formamidopyrimidine and to lesser extent the corresponding 
adenine de r iva t ives by base exc i s ion (Boiteux et al., 1992) . The 
formamidopyrimidine-DNA glycosylase protein appears to repair 8-oxodG 
in noncoding and actively transcribed mammalian DNA sequences with equal 
efficiency (Bohr et al., 1995). 
Biological Antioxidant Defences 
Under physiological conditions, aerobic organisms consume nearly 98% 
olecular oxygen at cytochrome a3 of the mitochondrial respiratory chain 
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(Chance et al., 1979). During this process, d ioxygen is reduced by four 
electrons, with no release of partially reduced oxygen intermediates 
(Malmstrom, 1982). Nevertheless , there is a fraction of 0 2 (1-2%) not 
consumed at cy tochrome a3 which is mono or divalent ly reduced to 
0 2 ' or H202 . These molecules can attack and i r revers ib ly damage a diverse 
spectrum of b iomolecules including proteins, phosphol ip ids , nucleic acids 
and sugars. 
Aerobic organisms have potent antioxidant defenses whose role is to 
neutralize and min imize the potentially cytotoxic and genotoxic effects of 
reactive oxidants . The defenses that directly decompose or scavenge, H202 
and 'OH are known as primary antioxidant defenses . There are also 
secondary ant ioxidant defenses which consist of the repair mechanisms that 
act on biomolecules that have undergone oxidat ive damage. 
(a) Enzymatic antioxidant defenses 
This group includes superoxide dismutase, ca ta lase and glutathione 
peroxidase. 
(i) Superoxide d ismutase : 
The enzyme superoxide dismutase catalyses the d ismuta t ion of 0 2 ' to H202 
(Fridovich, 1989). 
SOD 
0 2 - + 0 2 > H 2 0 2 + 0 2 
The SOD enzymes are a family of meta l loprote ins and tend to be high 
in tissues with high oxygen utilization and is inducib le by raising tissue 
P o 2 . 
(ii) Catalase: 
ase is a heme-prote in that decomposes H , 0 to O 
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Catalase 
2 H 2 0 2 -> 0 2 + 2H2© 
Catalase is present in the cytosol, mitochondria and other organelles, but 
is diffficult to detect in an extracellular environment . 
(iii) Glutathione perox idase : 
The selenium-based enzyme, glutathione peroxidase , reduces H202 by 
catalysing its reac t ion with the reduced form of gluthatione (GSH). 
glutathione 
H O +2GSH > 2H20+GSSG (oxidized glutathione) 
peroxidase 
Normally, most of the intracellular glutathione is in its reduced form. 
Increased in t race l lu lar concentrations of H 2 0 2 results in a drop in GSH/ 
GSSG ratio, which serves to detect intracellular oxidative stress (Tribble 
and Jones, 1990). 
(b) Non-enzymatic antioxidant mechanisms 
The ant ioxidant enzymes efficiently metabolize most cellular derived 
02"' and H 2 0 2 in different cell compartments. There is no enzymatic 
mechanism to d i rec t ly protect against 'OH because of its extremely high 
reactivity and rapid consumption. Alternatively, the cell possesses non-
enzymatic an t ioxidant mechanisms which scavenge 'OH. Some of these 
scavengers are hydrophi l ic (ascorbate, urate, glutathione) and others are 
hydrophobic ( a - t o c o p h e r o l , P-carotene). 
a- tocopherol (v i tamin E) is key 'OH scavenger and chain breaking 
antioxidant in b io logica l membranes (Niki et a/., 1988). It reacts with 'OH 
or most commonly with lipid peroxyl radical (LOO") to form the long lived 
cc-tocopheroxyl rad ica l . Vitamin E is important in protecting tissue from 
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a variety of physio-pathological insults which resul ts in enhanced tissue 
reactive oxygen species generation (Chow, 1991). 
The various defenses are complementary to each other since they 
metabolize or scavenge different species in different cellular compartments. 
The antioxidants armamentarium help to minimize the potentially deleterious 
effects of react ive oxidants. 
Autoimmunity 
The capaci ty of individuals to discriminate self from nonself is vital 
to the functioning of the immune system in order to defend against invading 
microorganisms (Tsao and Hahn, 1994). D i s rup t ion of self-nonself 
discrimination leads to autoimmunity (Deodhar, 1992). Burnet, in 1959 
predicted ingeniously that the immune system must generate a diversity 
of lymphocyte ant igen receptors through rapid somatic mutation in order 
to develop responsiveness to an enormous variety of antigens that has 
relevance to host defense. He also forecast correct ly that autoimmune 
lymphocyte c lones are produced during somatic mutat ion which need to be 
eliminated in order to prevent autoimmune disease . 
Normally, the immune system responds to a wide variety of foreign 
insults, such as bacteria , viruses, parasites and internal changes such as 
cancer, whi le not responding to one ' s own sel f antigens. During 
immunological disbalance as a result of internal threat, the bodys own 
tissue components become reactive and may result in the initiation of 
autoimmune process/diseases (Deodhar, 1992). Autoimmune diseases may be 
classified in different ways, it may be Tcell or ant ibody mediated, organ 
specific and systemic autoimmunity. 
The associat ion of certain serotype o f M H C antigens with autoimmune 
diseases has been and is still the subject of extens ive investigation. MHC 
molecules play a key role in the presentation of self antigens to T cell 
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precursors maturing in the thymus during which autoreactive clones are 
e l iminated through apoptosis. Hence , MHC antigens determine the shaping 
of the T cell repertoire released to the periphery. A failure of this thymic 
select ion could lead to autoimmune disease. A particular MHC molecule 
might delete T cells that normally suppress autoimmune responses in the 
per iphery or alternatively, might allow autoimmune T cell receptor to escape 
thymic delet ion (Mellins, 1992). According to Bottozo et al. (1983), an 
environmental trigger, either a microbe or a toxin, leads to t issue damage 
which re leases antigen from sites that were previously sequestered from the 
immune system. 
Possible Causes of Autoimmune Diseases 
Insp i te of the enormous progress in the knowledge of the immune 
react ion, the cause of autoimmunity is still unknown. Many theories have 
been proposed to explain the origin of autoimmune response. Based on 
various theories , the possible factors are discussed here. 
(a) Genetic factors 
It is well known that au to immune diseases show a highly significant 
familial predisposition. Relatives of pat ients with given autoimmune disease 
are known to be at high risk for developing the same disease. The majority 
of genes which have been associated with autoimmune diseases map within 
the MHC of man, or HLA region . The MHC is comprised of three 
functionally distinct and polymorphic gene clusters: classes I, II and III. 
Most of the MHC association with SLE, the prototype of autoimmune 
diseases , involve class II (HLA-DR and DQ alleles) and class III alleles 
especial ly null or deficiency a l le les of the fourth component (C4) of 
complement (Bias et al., 1986; Goldstein and Arnett, 1987; Braun and 
Zachary 1988; Arnett and Moulds , 1991; Deodhar, 1992). 
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(b) Humoral factors 
Autoimmune diseases occur far more commonly in females than in 
males , with a ratio of 10:1 or greater in certain diseases. The mechanisms 
involved are not clear, however, sex hormones, thymic hormones and 
corticosteroids play a significant role (Lahita and Kunkel, 1984). There has 
been considerable evidence suppor t ing the hypothesis that sex-related 
factors are involved in pathogenesis of SLE (Counihan et al., 1991; Lahita, 
1992). The female relatives of pa t ien ts with certain autoimmune diseases 
have been reported to d e m o n s t r a t e a significant p reva lence of 
autoantibodies and suppressor T cell defects (Miller and Schwartz, 1982). 
(c) Viral factors 
Viruses are frequently associated with autoimmune diseases of humans 
and animals (Krieg et al., 1989; 1991; Krieg and Steinberg, 1990; Steinberg 
et al., 1990). Such infectious agents may be acquired by horizontal or 
vertical transmission and may promote autoimmune reactions by varied 
mechanisms. Among the human v i ruses , Epstein-Barr virus (EBV) has been 
most prominently considered as a cause of autoimmune diseases because 
of its ubiquity, persistence and abi l i ty to act on the immune system. For 
example, EBV acts as a polyclonal B cell activator, stimulating mitosis and 
immunoglobulin secretion as well as promoting autoantibody production, 
especially rheumatoid factor (Gregory et al., 1991). 
(d) Polyclonal activators 
Polyclonal B and/or T cell ac t ivat ion has been proposed as a possible 
mechanism that may be responsible for the production of autoantibodies in 
certain autoimmune diseases, par t icu lar ly SLE (Dziarski, 1988). A large 
number of molecules, part icularly of microbial origin, have been found to 
act as polyclonal B cell a c t i va to r s and induce au toan t ibod ies 
(Theofilopoulos, 1993). Among the well known polyclonal B cell activators 
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are EB virus, endotoxin or lipopolysaccharide (LPS), cer ta in bacterial 
agents and drugs which may function in this fashion, bypass ing T cell 
regulatory mechanisms and act ivat ing B cells directly. The best example of 
human autoimmune disease in which such direct polyclonal act ivation may 
play a role is autoimmune thyroidit is (Goodman and Weig le , 1981). 
(e) Immunoregulation 
It is likely that cel lular immunity with anti-self p roper t i es is part of 
the normal immune response . Low affinity polyspecific antibodies and 
idiotypic antibodies may play a role in immunoregulation. It would seem 
that the malregulation of immune system would depend on multiple 
components of the feedback regulation system including T ce l l s , B cells 
and idiotypes (Shoenfeld and Schwartz, 1984). There are many components 
which have not been identif ied yet that can up or down regula te cells of 
the immune system. Normal ly , B cells with the po ten t ia l to produce 
autoantibodies are held in check by a lack of helper cel ls or an abundance 
of suppressor cells. Wide variety of autoimmune diseases such as SLE, 
Sjogren's syndrome, progress ive systemic sclerosis, rheumato id arthritis, 
pernicious anemia and many others are found to show an increased TH/TS 
ratio. 
(f) Tolerance 
Tolerance is a state of immunologic non-responsiveness to a substance 
that would be expected to evoke an immune response. Normal ly , humoral 
and cell-mediated immunity is suppressed against o n e ' s own antigens. 
Tolerance provides an essent ial mechanism for the prevent ion of self-injury. 
The impairment of self tolerance allows for autoimmune d i sease . Tolerance 
is accomplished through three mechanisms:- thymic educa t ion , thymic 
deletion and peripheral to lerance . Thymus is the major site for self-nonself 
discrimination. It is here that the T cell repertoire is de termined. Some 
cells are programmed to die (negative selection), whi le o thers are not 
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(positive selection) (Ador in i , 1993). Those with a high affinity for self 
ligands are negatively selected. It has also been suggested (Rose and 
Pittsbury, 1994) that thymus is the critical time keeper with ageing process 
with respect to immune response . Because thymus involutes asymmetrically, 
a clonal imbalance occurs with ageing, since the proport ion of autoantigen-
specific helper/inducer T cells increases as a function of autoantigen-
specific regulatory T ce l l s . Thus, circulating autoantibody level rises with 
age. As the thymic cor tex atrophies, the response to foreign antigens 
declines, whereas, the response to self antigens r ises, generat ing the ageing 
paradox. 
Systemic Lupus Erythematosus 
Systemic lupus ery thematosus (SLE) is considered to be the prototype 
of a spontaneous immune complex disease in which anti-DNA antibody-DNA 
complexes deposit in the t issue and induce inflammation (Naparstek and 
Madaio, 1997). SLE is episodic in its activity and variable in severity. 
Although, a clinically s imi lar syndrome can be induced by a variety of 
environmental agents (eg. certain drugs, microorganisms and immune 
stimulants). The e t io logy of the spontaneously occurr ing disorder is 
incompletely understood (Steinberg et al., 1990; 1991). Both genetic and 
environmental factors are believed to contribute to disease (Gourley et al., 
1992). Antigen-specific and nonspecific factors and polyclonal B cell 
activation may be r e spons ib l% for creating an environment that facilitates 
the expansion of autoant igen-specif ic clones (Schlomchik et al., 1987; 
Marion et al., 1989; Kl inman et al., 1990; Steinberg et al., 1990). 
The major serological marker of SLE, antibodies to double stranded 
DNA (Cepellini et al., 1957; Seligmann, 1957) is of paramount interest. 
The main reasons for this are the relationships seen in many, though not 
all patients with SLE, be tween levels of anti-dsDNA antibodies and clinical 
activity and the e lut ion of these antibodies from the kidneys of lupus 
patients and lupus-prone mouse models. In addition, al though antibodies to 
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single-stranded DNA are frequently found in the relatives of lupus patients, 
those b inding double stranded DNA are virtually never detected. The 
presence of anti-DNA autoantibodies in the sera of SLE patients has long 
been considered both as a marker of and pathologic factor in renal disease 
(Andres et al., 1970; Koffler et al., 1974). There are reports of serum anti-
dsDNA ant ibody levels correlating with the severity of the renal disease 
in SLE (Wallace et al., 1993). Various serological findings suggest that 
lupus nephri t is results from the deposition of DNA-anti-DNA complexes and 
subsequent complement mediated tissue damage (Emlen et al., 1986; 
Pisetsky, 1992). 
Hybr idoma technology and ant ibody sequencing have facili tated 
enormously the dissection of anti-DNA ant ibodies into features which may 
impart pathogenici ty and/or allow DNA recognit ion. Typically, the high 
affintiy an t i -dsDNA IgG which is ca t ionic produces tissue damage. 
Puttermann et al. (1996) report that charge and affinity may not predict 
potential for tissue damage. Recent studies of Swanson et al. (1996) 
indicate that an anti-ssDNA antibody may, on occassion, be a more potent 
immunogen compared to a dsDNA antibody. In addition, it has been 
suggested that it is not the positive charges which allow pathogenicity, but 
the number of charged (positive and negative) residues within the V-region 
which inf luences this property (Ohnishi et al., 1994). Before the onset of 
disease, the production of anti-DNA autoantibodies shifts markedly from 
IgM to IgG isotype (Papoian et al., 1974). The majority of the anti-DNA 
antibodies in the renal lesions are of the IgG2a and IgG2b sub-classes 
(Gallo et al., 1981). 
Apoptos is is an internally programmed cell death pathway (frequently 
initiated by extracellular signals) that regulates both T and B cell 
development (Smith et al., 1989). The process of apoptosis may provide 
a source of nuclear antigens to drive the autoantibody response and provide 
antigen in SLE (Emlen et al., 1994). Recent reports have suggested that 
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apoptosis may be abnormal in autoimmune disease and may play a role in 
the induction of autoimmunity (Fukunaga et al., 1992; Cohen and Eisenberg, 
1992). Finally, a recent report by Emlen et al. (1994) has demonstrated 
that the rate of apoptosis of lymphocytes derived from SLE patients was 
2.4 times faster than that seen in lymphocytes from normal controls or 
patients with rheumatoid ar thr i t i s (RA). 
There is increasing evidence to suggest a link between autoimmune 
diseases and cancer (Sela and Shoenfeld, 1988; Cash and Klippel , 1991; 
Kourtis et al., 1994; Seda and Alarcon, Segovia, 1995). The belief that 
SLE is associated with lymphoma is based on several case studies (Sela 
and Shoenfeld, 1988). Pa t ien ts who developed SLE later in life seemed most 
susceptible to cancer, which obviously reflects the higher incidence of 
cancer in older than in younger people (Petterson et al., 1992). 
MHC Gene Products in SLE 
A number of associa t ion of the disease itself and some of its 
serological features with gene products of MHC have been described in SLE 
(Bell and Maddison, 1980; Alvarel los et al., 1983; Shen and Winchestor, 
1986; Smolen et al., 1987 Hartung et al., 1989). In Caucas ians , SLE is 
associated with certain gene products of the MHC namely HLA-DR2 and 
the MHC haplotype B8-Bfs -C2C-C4AQO-C4B 1-DR3-DQ2 which are 
considered risk factors for SLE (Shen and Winchestor, 1986; Hartung et 
al., 1989). The appearance of some autoantibodies in SLE is associated 
with class II MHC produc t s , e.g. the Ro and La ant ibodies , which 
preferentially appear in HLA-DR3 positive SLE pa t i en t s (Bell and 
Maddison, 1980; Alvare l los et al., 1983; Smolen et al., 1987). High titre 
anti-ssDNA antibodies have been reported to be associated with HLA-DR2, 
suggesting a direct effect of MHC genes on autoant ibody formation. 
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Approach to Therapy 
Human lupus is a heterogeneous disorder with mul t ip le etiologies. Thus 
it seems unlikely that a specific etiology of the lupus syndrome will be 
worked out for each individual patient in the immediate future. If lupus 
is due to a loss of self to lerance, it may be possible to design a more 
general therapy to res tore self tolerance (Steinberg, 1994). Gene therapy, 
another approach to cur ing of lupus has been performed successfully in 
mice. Despite the power of modern molecular approaches and persisting 
investigative effort, lupus remains an enigmatic d isorder . The currently 
applied non-specific immunosuppressives, nonsteroidal anti-inflammatory 
drugs, rest are needed for chronic SLE patients (Blank et al., 1992). 
Provided that kidneys are not yet irreversibly damaged, the use of human 
soluble or chimeric receptors (constant part of human IgG heavy chain 
linked to the human soluble IFN-receptor) (Kurschner et al., 1992a,b) is 
an attractive prospective in the treatment of autoimmune glomerulonephritis 
in human SLE (Ozmen et al., 1995). 
Oxygen Free Radicals in SLE 
Oxygen derived species such as superoxide (Oy') and H , 0 , are 
produced in mammalian cel ls as a result of aerobic metabol i sm (Fridovich, 
1978; Halliwell and Gut te r idge , 1985). Excess generat ion of these species 
can result in damage to macromolecules, includinng DNA (Aruoma et al., 
1989) and have been implicated in the etiology of many human diseases 
(Halliwell and Gut ter idge , 1990; Lunec, 1990), inc luding SLE (Blount et 
al., 1994; Cooke et al., 1997). Damage to DNA induces strand breaks 
(Massie et al., 1972), s ister chromatid exchanges, subsequent production 
of clastogenic factors (Emeri t et al., 1985) and a l te ra t ion in DNA base 
structure (Teebor et al., 1988). 
8-Hydroxyguanosine (8-OHdG) is a specific marker of oxidative 
damage to DNA. It has been suggested that SLE cells are more susceptible 
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to oxidative stress. In addi t ion, both, normal and SLE cells exposed to H202 
showed a rapid conversion of dG to 8-OH-dG, suggesting that there is an 
equal susceptibility to damage . 
Blount et al. (1989) showed that modification of dsDNA by ROS 
results in an increased b inding of anti-DNA antibodies present in sera from 
SLE patients. ROS modif icat ion exposes base residues in the DNA backbone 
and minor regions of ssDNA (Blount et al., 1994), p roduc ing a more 
discriminating antigen for the diagnosis of SLE (Blount et al., 1990; Ara 
and Ali 1992; Ara et al., 1992; Alam et al.,1993) . ROS-DNA may, 
therefore, play a significant role in the generation of immune complexes 
which are of recognized importance in the pathogenesis of this disease 
(Lunec et al., 1994). 
Cancer 
The term cancer refers to more than hundred types of the disease. 
Almost every tissue in the body can spawn malignancies, some even yield 
several types, with each cancer having unique features. The thirty trillion 
cells of the normal heal thy body live in a complex, interdependent 
condominium, regulating one another ' s proliferation. Indeed, normal cells 
reproduce only when instructed to do so by other cells in their vicinity. 
Cancer cells in contrast, v iolate the scheme, they become deaf to the usual 
control on prol i ferat ion and follow their own in te rna l agenda for 
reproduction. They also possess an even more insidious proper ty to migrate 
from the site where they or iginate , and form masses at dis tant sites in 
the body (Weinberg, 1996). 
The changes in DNA like base modification, rear rangement of DNA 
sequence, miscoding of DNA lesion, gene duplication and the activation of 
oncogenes may involve in the initiation of various cancers (Cavenee and 
White, 1995). Cancer progress ion is a stepwise process where the initiated 
cells, nodules, polyp or the papi l loma, evolve into a cancer and further step 
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as the cancer becomes progress ively more malignant. 
The genes implicated in the malignancy are often modified forms of 
the human genes. The act ivat ion of protooncogenes into oncogenes, the 
product of which when al tered contribute to malignancy. Mutation can also 
convert proto-oncogene into carcinogenic oncogenes. Studies revealed the 
presence of human c-onc genes with several being act ive (Marshall , 1985). 
These genes were mutated, rearranged or unusually act ive in many viral 
and non-viral tumors. Lack of c-onc in retroviruses make oncogenic, giving 
rise to tumors more slowly than those with v-onc genes (Weiss , 1986). In 
most of the cases, the re t rovira l genome integrates adjacent to the c-myc 
gene and in some cases, hybrid viral c-myc RNA transcript could be 
demonstrated (Hayward et al., 1981). Translocation of chromosome in 
human cancer cell bring one gene into juxtaposition with active regions for 
gene expression leading to their constitutive expression (Klein and Klein, 
1984). The point mutat ion of cellular ras genes leads to oncogenic 
versions resulting in s ingle codon changes (Marshall , 1985). 
Role of Oxygen Free Radicals in Cancer Development 
Oxygen derived species such as superoxide radical (02*)> H 20 2 , singlet 
oxygen and hydroxyl radical ( 'OH) are well known to be cytotoxic and have 
been implicated in the e t io logy of a number of human diseases including 
cancer (Cerutti, 1985; Hal l iwel l and Gutteridge, 1989). 
Mutagens, tumor p romote r s and a variety of carc inogens including 
benzene, aflatoxin and benzo(a)pyrene may exert their effect partly by 
generating ROS during their metabolism (Mauthe et al., 1995; Shen et al., 
1995). 
Mutations caused by oxidat ive DNA damage include a range of 
specifically oxidized pur ines and pyrimidines as welll as alkali labile sites 
and single strand b r e a k s , formed directly or by repa i r processes 
32 
(Dizdaroglu, 1994; Breen and Murphy, 1995). Because of the multiplicity 
of DNA modifications produced by oxygen free radicals, it has been difficult 
to establish the frequency and specificity of mutation engendered by 
individual oxygen induced lesions (Cheng et al., 1992). Studies show that 
although all the four bases are modified by ROS, mutations are usually 
related to modification of GC base pairs, while modifications of AT base 
pairs, rarely lead to mutations (Retel et al., 1993). These mutations are 
usually base pair substitutions, whereas, base deletions and insertions are 
less frequent. In human tumors, G to T transversions are the most frequent 
mutations in the p53 supressor gene (Hollstein, et al., 1991; Harris and 
Hollstein, 1993). Oxidative damage to cellular DNA can be mutagenic and 
may, therefore , play an important role in tumorigenesis. It has been shown 
that 8-hydroxydeoxyguanosine is mutagenic (Kuchino, et al., 1987) and can 
result in act ivation of the human c-Has-ras-1 gene (Kamiya et al., 1992). 
Using s ingle stranded DNA template in a sensitive forward mutation 
system, var ious mutations, including tandem double CC—>TT substi tution 
have been observed in DNA treated with oxygen free radicals (Reid and 
Loeb, 1993). The tandem double CC—>TT mutation induced by free 
radicals have also been found in the p53 gene of skin squamous cell 
carcinoma (Brash et al., 1991). 
Elevated levels of modifed bases in cancerous tissue may be due to 
the product ion of large amounts of H 2 0 2 , which has been found to be 
characterist ic of human tumor cells (Szatrowski and Nathan, 1991). Further, 
evidence exists that tumor cells have abnormal levels and activit ies of 
antioxidant enzymes, such as superoxide dismutase or catalase in tumor 
cells leading to accumulation of 0 2 ' and H 2 0 2 that induced damage to DNA 
(Olinski et al., 1992). 
The toxici ty of 0 2 ' and H202 is thought to result from their metal ion 
catalyzed conversion into highly reative 'OH (Cerutti, 1985; Fridovich, 
1986; Hal l iwel l and Aruoma, 1991). Free radical induced damage to DNA 
in vivo is implicated to play a role in carcinogenesis (Olinski et al., 1992; 
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Kasprazak, 1995). 
Init iation of cancer in humans by oxygen free radicals is further 
supported by the presence of oxidative DNA modifications in cancer tissue 
(Ames et al., 1993b). Thus, lungs from cancer patients contain 25-75 8-
oxo-dG per 105 deoxyguanosine in the apparently normal tissue and two 
to three fold higher values in the tumor (Olinski et al., 1992). Exposure 
of cell cultures to cigarette smoke causes accumulation of 8-oxo-dG (Fraga 
et al., 1990). Cigarette smoke is rich in carcinogens such as ni t rosoamines , 
acrolein and carcinogenic hydrocarbons (Elserich et al., 1994). These events 
could be involved in the production of muta t ions by components of cigaret te 
smoke, some of which might be media ted by DNA damage induced by 
oxygen free radicals. Urine obtained from smokers also has a 4-10 fold 
elevation in altered nucleotides that are known to be produced by oxygen 
free radicals (Fraga et al., 1990). 
Carcinoma of hepatic cell is often associated with chronic infection 
by hepati t is B or C viruses (Blumberg et al., 1975; Hagen et al., 1994) 
or ingestion of aflatoxin (Ross et al., 1992). G to T transversion has been 
shown to be one of the more common types of mutations produced by 
aflatoxin lesion and oxygen free radica ls damage to DNA (McBride et 
al., 1991). The 8-oxo-dG has been repor ted to accumulate in hepatocel lu lar 
cancer (Ogawa et al., 1995; Wang et al., 1995) and the consequent 
carcinoma developed by etinyl es t radiol have been reduced by an t iox idants , 
vitamin C, E and P-carotene (Ogawa et al., 1995). The measurement of 
DNA damage and mutation in human liver as function of pers is tence of 
chronic hepatit is might be predict ive for the onset of liver cancer . 
Chronic prostate hypertrophy is diagnosed in most males by the age 
of 40 years, but the late appearance of prostat ic carcinoma sugges ts that 
a multistep process is involved in tumorigenes is . The paucity of known 
chemical agents associated with pros ta te cancer indicates an assoc ia t ion 
with endogenous cellular processes (Feig et al., 1994). The most r easonab le 
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candidate for endogenously formed genotoxins that accumulate in later life 
are the oxygen free radicals . 
Oxidat ive DNA damage may be involved in the development of breast 
cancer. Increased steady-state levels of DNA base damage with a pattern 
character is t ic of 'OH attack, have been reported in DNA from invasive 
ductal carcinoma (Malins et al., 1993). Breast cancer represents about 20-
29% and account for 15-18% of morta l i ty (Pasqualine, 1994). DNA damage 
by ROS is also implicated in inflammatory breast disease (Jaiyesimi et al., 
1992), where malignant progression can occur. It is reported that elevated 
levels of 8-oxo-dG adducts in DNA play a fundamental role in breast cancer 
(Malins and Haimanot, 1991). Evidence also exists for the progression of 
breast tumor to the metastatic stage and is an important et iologic factor 
(Malins et al., 1996). 
The epidemiological studies involving measurement of typical radical 
modified DNA bases in a large variety of individual tumor t issue and their 
respect ive normal tissues may provide insight in to the mechanism of 
carcinogenesis related to oxygen derived species. Measurement of purine 
and pyr imidine derived DNA lesions in tissue may prove to be useful in 
determining an association between free radical producing agents and cancer 
risk. 
Objectives of the Present Study 
Autoantibody hyperproduction and injury of multiple organs and tissues 
are the hallmark of systemic autoimmune diseases. It is not clear whether 
some form of DNA, such as product of viral infection or a fragment of 
chromatin or chemically modified DNA serves as immunogen. 
In the present work, calf thymus DNA was purified free of proteins 
and s ingle stranded regions . The purified DNA was modif ied with 
superoxide radical generated by i l lumination of riboflavin with fluorescent 
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light. The modifications on DNA were studied by UV spectroscopy, 
thermal denaturation s tudies , sedimentation in alkaline sucrose density 
gradient, nuclease SI d iges t ib i l i ty , circular dichroism spectroscopy and 
hydroxyapatite column chromatography. DEAE-Sephadex A 25 was used to 
quantify base modification in modified DNA. 
The antigenicity of superoxide modified DNA was probed by inducing 
polyclonal antibodies in experimental animals. The repertoire of specificities 
of induced antibodies was evaluated by their binding using direct binding 
and competi t ion ELISA. Natura l ly occurring human anti-DNA 
autoantibodies and antibodies in sera of various cancer pat ients was also 
studied by native and superoxide modified DNA. 
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MATERIALS 
Calf thymus DNA, nuclease S,, riboflavin, superoxide dismutase, 
catalase, bovine serum albumin, agarose, ant i -human/ant i - rabbi t IgG-
alkaline phosphatase, ant i-rat-IgG-HRP and FITC conjugates , ethidium 
bromide, Coomassie Bri l l iant Blue G 250 and R 250, standard protein 
markers, sodium dodecyl sulphate , Freund's comple te and incomplete 
adjuvants, methylated bovine serum albumin, Tween-20, Triton X-100 and 
nitroblue tetrazolium were purchased from Sigma Chemical Company, 
U.S.A. Synthetic po lynuc leo t ides , Protein A-Sepharose CL-4B, DEAE 
Sephadex A-25 and Ficoll 400 were obtained from Pharmacia Fine 
Chemicals, Sweden. EDTA (disodium salt), chloroform, isoamyl alcohol and 
hydrogen peroxide were from Qualigens, India. 
Polystyrene microt i t re flat bottom ELISA plates having 96 wells (7 mm 
diameter) were purchased from Nunc, Denmark, p -n i t rophenyl phosphate 
and Folin- Ciocalteau reagent were obtained from Centre for Biochemical 
Technology, New Delhi. Acrylamide, ammonium persu lphate , bisacrylamide, 
hydroxyapatite, N,N,N' ,N ' - te t ramethyle thylene d iamine (TEMED) were 
from Bio-Rad Laborator ies , U.S.A. Diphenylamine and ethanol were 
chemically pure. All other chemicals were of highest analytical grade 
available. 
Equipment 
Shimadzu UV-240 spectrophotometer equipped with thermo-program-
mer and controller unit, ELISA microplate reader MR-600 (Dynatech, 
U.S.A.), ELISA microplate washer (Denley, England) , ELICO pH meter 
model Ll-120, gel scanner GSC-3A, ultraviolet lamp (Vilber Lourmat, 
France), agarose gel e lect rophoresis assembly (GNA-100) and gradient 
mixer GM-1 (Pharmacia, Sweden) , Beckman Ultracentrifuge, Avanti 30 table 
top high speed refrigerated centrifuge (Beckman, U.S .A. ) , polyacrylamide 
gel electrophoresis assembly (Bio-Rad, U.S.A.), and fluorescent microscooe 
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(Nikon, Japan) were the major equipment used in this study. 
Collection of Sera 
SLE sera were obtained from patients showing high titre anti-DNA 
antibodies and fulfilled the American College of Rheumatology criteria for 
the diagnosis of SLE (Arnett et al., 1988). Normal human sera were 
obtained from heal thy individuals and stored in small al iquots at -20°C Sera 
of patients with cancer proven with his topathological diagnosis were 
obtained from J.N. Medical College Hospital of A.M.U. , Aligarh. Sera were 
decomplemented by heating at 56°C for 30 min and stored in aliquots at 
-20°C. 
METHODS 
Purification of Calf Thymus DNA 
Highly polymerized calf thymus DNA was purif ied free of proteins, 
RNA and single s tranded regions as described by Ali et al. (1985). The 
DNA (2 mg/ml) was dissolved in 0.1X SSC (15 mM sodium citrate and 
150 mM sodium chlor ide) , pH 7.3 and extracted with a mixture of 
chloroform-isoamyl alcohol (2,4:1) in a stoppered measuring cylinder for 
1 hr. The aqueous layer containing DNA was separated from the organic 
layer and re-extracted with chloroform-isoamyl a lcohol . The DNA was 
precipitated with two volumes of cold absolute e thanol and collected on 
a glass rod. After drying in air, the DNA was dissolved in 30 mM acetate 
buffer, pH 5.0 conta in ing 30 mM zinc chloride and treated with nuclease 
S, (200 units/mg DNA) at 37°C for 30 min to remove single stranded 
regions. The reaction was stopped by adding one- tenth volume of 200 mM 
EDTA, pH 8.0. Extract ion procedure was repeated as before and final 
preparation of DNA was dissolved in phosphate-buffered saline (PBS), pH 
7.4. 
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Determination of DNA Concentration 
The concentration of DNA was determined by the method of Burton 
(1956). 
(a) Crystallization of diphenylamine 
Diphenylamine (2 gm) was dissolved in 200 ml boiling hexane . 
Approximately 0.5 gm of activated animal charcoal was added and fi l tered 
through Whatman No. 1 filter paper. The filtrate was kept overnight at 
4°C. Diphenylamine crystals so obta ined, were again filtered to remove 
hexane and finally dried at room tempera ture . 
(b) Preparation of diphenylamine reagent 
Recrystal l ized diphenylamine (750 mg) was dissolved in 50 ml glacial 
acetic acid containing 0.75 ml concentra ted sulphuric acid. 
(c) Procedure 
One ml of 1 N perchloric acid was added to 1.0 ml of DNA sample 
and incubated in a thermostat water bath at 70°C for 15 min. One hundred 
microli tre of 5.43 mM acetaldehyde was added followed by 2.0 ml of freshly 
prepared diphenylamine reagent. The contents were mixed and incubated at 
room temperature for 16-20 hr. and absorbance was recorded at 600 nm. 
The DNA concentration in unknown samples was determined using calf 
thymus DNA as standard. 
Determination of Protein Concentration 
Protein was estimated by the methods of Lowry et al. (1951) and 
Bradford (1976). 
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Protein estimation by Folin's-phenol reagent 
Prote in estimation by this method ut i l izes alkali (to keep the pH high), 
Cu2* ions (to chelate proteins) and tar tarate (to keep the Cu2~ ions in 
solution at high pH). 
(a) Folin-Ciocalteau reagent 
The reagent was purchased from Centre for Biochemical Technology, 
New Delhi and diluted 1:4 with dis t i l led water before use. 
(b) Alkaline copper reagent 
The components of alkaline copper reagent were prepared as follows: 
(i) Two percent sodium carbonate in 100 mM sodium hydroxide 
(ii) 0.5 percent copper sulphate in 1.0 percent sodium potassium tartarate . 
The working reagent was prepared fresh before use by mixing 
components (i) and (ii) in the rat io of 50:1. 
(c) Procedure 
To 1.0 ml of protein sample was added 5.0 ml of alkaline copper 
reagent . The samples were allowed to stand at room temperature for 10 
min. Working Folin-Ciocalteau reagent (1.0 ml) was added to the tubes, 
mixed and incubated for 30 min at room temperature. The absorbance 
was read at 660 nm. The concentra t ion of protein in unknown sample was 
determined from a standard plot of bovine serum albumin. 
Protein estimation by Bradford method 
This assay is based on colour change that occurs when Coomassie 
Bri l l iant Blue G 250 in acidic medium, binds strongly to protein 
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hydrophobically and at posi t ively charged groups (Bradford, 1976). In the 
environment of these posi t ively charged groups, protonation is suppressed 
and a blue colour is observed (X - 595 nm). 
(a) Dye preparation 
One hundred mg Coomassie Brill iant Blue G 250 was dissolved in 50 
ml of 95% ethanol. To this solution was added 100 ml of 85% (v/v) 
orthophosphoric acid. The resul t ing solution was diluted to a final volume 
of 1 l i tre. 
(b) Protein assay 
To solutions containing 10-100 ug protein in a volume of up to 0.1 
ml was added 5 ml of dye solution and contents mixed by vor texing. The 
absorbance was taken at 595 nm after 5 min against a reagent blank. 
Modification of Calf Thymus DNA by Superoxide Anion 
Radicals 
Superoxide radical was detected by photosensitized reduct ion of 
ni troblue tetrazolium (NBT), leading to the formation of a blue coloured 
product , nitroblue formazan (Nakayama et al., 1983). In order to identify 
superoxide radical ( 0 2 ) , superoxide dismutase and other react ive oxygen 
species scavengers were added to the buffer before in t roducing the 
chemicals. 
Native calf thymus DNA was modified by the method of Naseem et 
al. (1988). A total volume of 3.0 ml contained, 100 ug/ml DNA, 50 mM 
potassium phosphate buffer, pH 7.8, 0.033 uM NBT, 0.1 mM EDTA, 0.06% 
Triton X-100 and 40 uM riboflavin. Immediately after mixing, the reaction 
was carried out in the presence of white fluorescent light at room 
temperature. The samples were dialyzed extensively to remove riboflavin 
and Triton X-100. 
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Spectroscopic Analysis 
The ul t raviolet spectra of modified and unmodified DNA were recorded 
in the wavelength range of 200-400 nm on a Shimadzu UV-240 
spectrophotometer. 
Circular Dichroism Measurements 
The CD spectra were taken on a Jasco J-700 spectropolarimeter using 
quartz cell of 1 cm path length. Circular d ichroic (CD) spectra of native 
and superoxide modified DNA were performed in the wavelength range from 
220 nm to 350 nm. Scans were recorded at 0.2 nm intervals. The 
concentration of DNA was 151 uM base pair . Molar ellipticities were 
calculated in terms of the base pair concentra t ion according to following 
equation 
e 
[0] = 
lOcl 
where, 0 = Measured ellipticity (mdeg) 
c = Molar concentration of DNA 
1 = Path length in cm 
Absorption-Temperature Scan 
Thermal denaturation analysis of nucleic acids was performed in order 
to ascertain the degree of modification incurred on the nucleic acids by 
determining mid point melting temperature (Tm). Native and modified 
samples were subjected to heat denaturat ion on a Shimadzu UV-240 
spectrophotometer coupled with a temperature programmer and controller 
assembly (Hasan and Ali, 1990). All the samples were melted from 30°C 
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to 95°C at a rate of 1.5°C/min after 10 min equilibration at 30°C. The 
change in absorbance at 260 nm was recorded with increasing temperature. 
Percent denaturat ion was calculated as fol lows: 
Percent denaturation = x 100 
A
 - A.n 
max 30 
Where, A^ = Absorbance at a tempera ture T°C 
A = Final maximum absorbance on the completion of 
max r 
denaturation (95°C) 
A30 = Initial absorbance at 30°C 
Hydroxyapatite Column Chromatography 
Hydroxyapat i te column chromatography was employed to differentiate 
nucleic acids endowed with different secondary structures. DNA and 
superoxide modified DNA (in 10 mM Na-phosphate buffer, pH 6.8) were 
chromatographed on hydroxyapatite column as described by Dardalhon and 
Averback (1988) . Batch elution was carried out with 125 mM and 250 mM 
Na-K-phosphate buffer, pH 6.8 at a flow rate of 15 ml/hr and fractions 
of 3 ml were collected and absorbance monitored at 260 nm. 
Detection of Strand Breaks 
The damage to DNA induced by superoxide anion radical was 
ascertained by alkaline sucrose density ultracentrifugation and nuclease S, 
digestibility. 
(a) Alkal ine Sucrose Density Gradient Ultracentrifugation 
Native and superoxide modified DNA (0.2 ml) were treated by the 
addition of an equal volume of 0.2 N NaOH. After 10 min to allow 
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denaturation of DNA, 0.4 ml sample was layered on top of a linear 4.6 
ml alkaline sucrose gradient (5-20% sucrose in 0.1 N NaOH and 10 mM 
EDTA) (Ali and Sauerbier, 1978). The gradients were centrifuged at 30,000 
rpm for 1 hr at room temperature in swinging bucket rotor of Beckman 
ultracentrifuge. The bottom of the tubes were pierced and six drop fractions 
were collected, diluted to about 0.5 ml with distilled water and their 
absorbance recorded at 260 nm. 
(b) Nuclease Sx Digestibility 
Native and superoxide modified DNA were characterized by nuclease 
S, digestibility (Matsuo and Ross, 1987). One microgram each of native 
and modified DNA in acetate buffer (30 mM each of sodium acetate and 
zinc chloride, pH 5.0) were treated with nuclease S] (20 units/ug DNA) 
for 30 min at 37°C. The reaction was stopped by adding one tenth volume 
of 200 mM EDTA, pH 8.0. The digested and control samples were subjected 
to agarose gel electrophoresis. 
(i) Gel preparation 
Agarose (1%) in TAE buffer (40 mM Tris-acetate, pH 8.0 containing 
2 mM EDTA) was dissolved by heating. The solution was cooled to about 
50°C and then poured into the gel tray and allowed to solidify at room 
temperature. 
(i i) Sample preparation and loading 
Native and superoxide modified DNA samples treated with nuclease S, 
were mixed with one-tenth volume of sample buffer (0.125% bromophenol 
blue, 30% Ficoll 400, 500 mM EDTA in 10X electrophoresis buffer). The 
samples were loaded in the wells and electrophoresed for 2 hr at 30 mA. 
The gels were stained with ethidium bromide (0.5 ug/ml), viewed by 
illumination under UV light and photographed. 
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Separation of DNA Bases 
The separation and quantitation of bases in na t ive and superoxide 
modified DNA was carried out according to Hasan and Ali (1990). 
(a) Acid hydrolysis of DNA samples 
Native and superoxide modified DNA samples were treated with 70% 
perchloric acid. The samples were heated at 100°C for 1 hr to release the 
bases. The hydro lyza te was neutralized and the bases were separated on 
DEAE Sephadex A-25 column. 
(b) DEAE Sephadex A-25 column chromatography 
The swollen ion exchanger was mixed with equi l ib ra t ing buffer (1 mM 
Tris-HCl, pH 7.6) and packed in a column (40 cm x 0.75 cm). The column 
was equilibrated with the same buffer and 3 ml of sample was applied onto 
the column and eluted with a linear gradient of 1-20 mM Tris-HCl, pH 7.6, 
at a flow rate of 40 ml/hr . Three ml fractions were col lec ted and absorbance 
read at 260 nm. The control experiments were carr ied out with individual 
bases and hydrolyzed native DNA in order to locate the pattern of 
unmodified bases . 
Immunization Schedule 
Native and superoxide modified DNA (100 ug) were complexed with 
an equal amount (w/w) of methylated BSA and emulsif ied with an equal 
volume of comple te F reund ' s adjuvant and injected intramuscularly in 
rabbits. Subsequent injections were given in incomple te Freund 's adjuvant. 
Each animal received a total of 500 ug of ant igen in the course of five 
injections. Blood was collected by cardiac punc ture , serum was separated 
and decomplemented by heating at 56°C for 30 min. Pre- immune serum was 
collected prior to immunizat ion. The sera were s tored in small aliquots at 
-80°C with 0 . 1 % sodium azide as preservative. 
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Four female rats (Sprague-Dawley), were immunized with native and 
superoxide modified DNA (50 ug/rat) subcutaneously. The antigen was 
complexed with methylated BSA and emulsified in Freund's complete 
adjuvant. Three booster doses (each 25 ug/rat) were given intraperitoneally 
at weekly intervals with incomplete adjuvant. The control group did not 
receive any ant igen. Animals were bled by cardiac puncture and blood was 
collected. Serum was separated and decomplemented by heating at 56°C 
for 30 min and stored at -80°C with 0 . 1 % sodium azide as preservative. 
Rats were sacrificed and their kidneys were removed and stored at -
80°C. 
Immunofluorescence 
Kidney sect ions (approx. 5 urn thick) were sliced and fixed on slides 
with acetone and incubated with anti-rat IgG fluorescein isothiocyanate 
conjugate (1:100 di lu ted) for 30 min. The fixed sections on slides were 
washed three t imes with PBS and mounted with 50% glycerol. The slides 
were then viewed under a fluorescent microscope. 
Isolation of IgG by Protein A-Sepharose CL-4B 
Serum IgG was isolated by affinity chromatography on Protein A-
Sepharose CL-4B column. Serum (0.5 ml) diluted with equal volume of 
PBS, pH 7.4 was applied to column (0.9 cm x 15 cm) equilibrated with 
the same buffer. The wash through was recycled 2-3 times. Unbound IgG 
was removed by extensive washing with PBS, pH 7.4. The bound IgG 
was eluted with 0 .58% acetic acid in 0.85% sodium chloride (Goding, 1976) 
and neutralized with 1 ml of 1 M Tris-HCl, pH 8.5. Three ml fractions 
were collected and read at 251 nm and 278 nm. The IgG concentration 
was determined consider ing 1.4 O.D2g0 = 1.0 mg IgG/ml. The isolated IgG 
was then dialyzed against PBS, pH 7.4 and stored at -20°C with 0 .1% 
sodium azide. 
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Polyacrylamide Gel Electrophoresis For Proteins 
Polyacrylamide slab gel electrophoresis was performed under denatur-
ing condi t ions as described by Laemmli (1970). The following stock 
solutions were prepared: 
(i) Acrylamide-bisacrylamide (30:0.8) 
A stock solution was prepared by dissolving 30 gm of acrylamide and 
0.8 gm bisacrylamide in distilled water to a final volume of 100 ml. 
(ii) Resolving gel buffer 
A stock solution was prepared by dissolving 36.3 gm Tris base in 48.0 
ml of 1 N HC1. The contents were mixed, pH adjusted to 8.8 and the final 
volume brought to 100 ml with disti l led water. 
(Hi) Stacking gel buffer 
6.05 gm Tris was dissolved in 40 ml dist i l led water, pH titrated to 
pH 6.8 with 1 N HC1 and the final volume adjusted to 100 ml with disti l led 
water. 
(iv) Electrode buffer 
3.03 gm Tris, 14.4 gm glycine and 1.0 gm SDS were dissolved in 
distilled water, pH adjusted to 8.3 and final volume made up to one l i t re . 
(v) Procedure 
Glass plates, separated by 1.5 mm thick spacer were sealed with 1% 
agarose. The resolving gel mixture was prepared by mixing the components 
in the appropriate volume and poured in to the space between the glass 
plates leaving sufficient space at the top for the stacking gel. After the 
polymerizat ion of separating gel, s tacking gel mixture was poured and 
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allowed to solidify. Protein samples containing 10% glycerol and 0.002% 
bromophenol blue were applied and electrophoresis was carried out at 
60 V for 6-8 hr. Staining of the gel was achieved with 0 .1% Coomassie 
Bril l iant Blue R 250 (in 25% isopropanol and 10% glacial acetic acid). 
Destaining was carried out in a mixture of 10% acetic acid and 10% 
methanol. 
Recipe for 7.5% SDS-PAGE 
Solutions Stacking gel Resolving gel 
Acrylamide-bisacrylamide 
Stacking gel buffer 
1.25 ml 
2.5 ml 
7.5 ml 
Resolving gel buffer 
Dist i l led water 5.65 ml 
3.75 ml 
16.95 ml 
10% SDS 0.1 ml 0.3 ml 
1.5% Ammonium persulphate 0.5 ml 1.5 ml 
TEMED 0.75 uL 15 uL 
Immunological Detection of Antibodies 
Sera were tested for a n t i b o d i e s by i m m u n o d i f f u s i o n , 
counterimmunoelectrophoresis , enzyme linked immunosorbent assay and gel 
retardation assay. 
(a) Immunodiffusion 
Immunodiffusion (ID) was carried out by Ouchterlony double diffusion 
system. Six ml of 0.4% molten agarose in PBS containing 0 . 1 % sodium 
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azide was poured on to glass petridishes and allowed to solidify at room 
temperature . Wells of 5 mm diameter were cut into hardened gel and an 
appropriate concentration of antigen and antibody was placed in the wells. 
The petridishes were allowed to stand in a moist chamber at room 
temperature for 48-72 hr. The gels were washed with 5% sodium citrate 
to remove non-specific precipitin l ines . The result was analyzed visual ly. 
(b) Counterimmunoelectrophoresis 
Counterimmunoelectrophoresis (CIE) was performed by the method of 
Kurata and Tan (1976) using 0.6% molten agarose solution in 25 mM 
barbital buffer, pH 8.4 containing 0 . 1 % sodium azide. Agarose was poured 
on to 2.5 mm thick glass slides (7.5 cm x 2.5 cm) and allowed to harden 
at room temperature and then at 4°C. Wells each 3 mm in diameter were 
cut and loaded with antigen and ant ibodies (in anodal and cathodal wells , 
respect ively) . Electrophoresis was performed for 30 min in 50 mM barbital 
buffer, pH 8.4 with a current of 3-4 mA per slide. Non-specific precipi t in 
lines were removed with 5% sodium citrate. 
(c) Enzyme Linked Immunosorbent Assay 
The following reagents were prepared in distilled water and used in 
enzyme immunoassay. 
(i) Buffers and reagents 
Tris buffered saline (TBS) 
10 mM Tris, 150 mM NaCl, pH 7.4 
Tris buffered saline-Tween 20 (TBS-T) 
20 mM Tris, 144 mM NaCl, 2.68 mM KCl, pH 7.4, containing 500 uL Tween 
20/L 
49 
Carbonate-bicarbonate buffer 
15 mM sodium carbonate, 35 mM sodium bicarbonate, pH 9.6, containing 
2 mM magnesium chloride 
Citrate-phosphate buffer 
50 mM citric acid, 50 mM N a 2 H P 0 4 ' P H 5 0 
Substrates 
(i) 500 ug p-nitrophenyl phosphate(p-NPP)/ml carbonate-bicarbonate 
buffer 
(ii) 500 ug o-phenylene diamine (OPD)/ml ci t rate-phosphate buffer, 
containing 1 ul/ml of hydrogen peroxide 
(ii) Procedure 
Antibodies were detected by ELISA using polystyrene micro t i te r plates 
as solid support (Aotsuka et al., 1979). One hundred microl i t re of 2.5 ug/ 
ml antigen in TBS, pH 7.4 was coated in test wells of micro t i t re plates, 
incubated for 2 hr at 37°C and overnight at 4°C. The antigen coated wells 
were washed three times with TBS-T to remove unbound antigen. 
Unoccupied sites were blocked with 150 uL of 1.5% BSA in TBS for 
4-5 hr at room temperature. The plates washed once with TBS-T and 
antibody (100 ul/well) to be tested, were diluted in TBS was added to each 
well. After 2 hr incubation at 37°C and overnight at 4°C, the plates were 
washed four times with TBS-T and an appropriate ant i - immunoglobul in 
alkaline phosphatase or HRP conjugate was added to each wel l . After 
incubation at 37°C for 2 hr, the plates were washed four t imes with 
TBS-T and three times with dist i l led water and developed using p-
nitrophenyl phosphate or orthophenylenediamine ( O P D / H , 0 , ) substrate 
respectively. The plates were incubated for 1-2 hr and reac t ion stopped in 
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the case of O P D / H 2 0 2 system with 50 ul of 5 N H 2 S0 4 and read at 490 
nm. In the case of p-NPP, the absorbance was read at 410 nm on an 
automatic micropla te reader. Each sample was run in duplicate. The control 
wells were t reated similarly but were devoid of antigen. Results were 
expressed as a mean of A - A 
r
 tesl control 
Competition ELISA 
The ant igenic specificity of the antibodies was determined by 
competition ELISA (Hasan et al., 1991). Varying amounts of inhibitors 
(0-20 ug/ml) were mixed with a constant amount of antiserum or IgG. The 
mixture was incubated at room temperature for 2 hr and overnight at 4°C. 
The immune complex thus formed was coated in the wells instead of the 
serum. The remain ing steps were the same as in direct binding ELISA. 
Percent inhibi t ion was calculated using the formula 
Percent inhibition = 1 
Band Shift Assay 
For the visual detection of antigen-antibody binding and immune 
complex formation, gel retardation assay was performed (Sanford et al., 
1988). A constant amount of antigen (native and superoxide modified DNA) 
was incubated with varying amounts of IgG in PBS, pH 7.4 for 2 hr at 
37°C and overnight at 4°C. One-tenth volume of ' s top mix ' dye was added 
to the mixture and electrophoresed on 1% agarose for 2 hr at 30 mA in 
TAE buffer, pH 7.9. The gels were stained with ethidium bromide (0.5 ug/ 
ml), visualized under UV light and photographed. 
Quantitative Precipitin Titration 
The immunointerac t ion between antigen and antibody was investigated 
by precipitin ana lys i s under equilibrium condi t ions . Increasing amounts of 
i n h i b i t e d 
u n i n h i b i t e d 
x 100 
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antigens (0-40 ug) were mixed with 100 ug each of IgG in an assay volume 
of 0.2 ml. The mixture was incubated at 37°C for 2 hr and overnight at 
4°C. The tubes were centrifuged at 10,000 rpm for 5 min. The precipitate 
was washed with cold PBS, pH 7.4 and dissolved in a fixed volume 
of 1 M NaCl . The amount of bound and unbound antigen and antibody in 
the dissociated immune complex supernatant was determined. For antigen 
diphenylamine reagent (Burton, 1956) and for antibody dye binding method 
(Bradford, 1976) was used. The binding data was analyzed and antibody 
affinity was calculated (Langmuir, 1918). 
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Photochemical Generation of Superoxide Anion 
Radical 
Superoxide anion radicals were generated by illumination of riboflavin 
with fluorescent light. The generation of superoxide anion radicals was 
observed by reduction of nitroblue te t razol ium (NBT) (Fig.2). In order to 
optimize the superoxide generation, the t ime of illumination and dose 
dependent response of riboflavin and Tri ton X-100 was studied. The results 
showed an increase in absorbance at 560 nm with increasing time period 
of i l lumination. It is evident from the curve that 20 min of i l lumination 
of 800 lux of white fluorescent light caused optimum generation of 
superoxide radical (Fig. 2). Similarly, dose dependent experiments were 
carried out with varying amounts of r iboflavin (Fig. 3) and Triton X-
100 (Fig. 4). The optimum production of superoxide radical was observed 
at 15 uM of riboflavin and 1050 ul (0 .21%) of Triton X-100. 
The increase in abosrbance at 560 nm was inhibited by the addit ion 
of superoxide dismutase (SOD), while inact ivated SOD showed no inhibitory 
effect (Fig. 5), indicating the generat ion of superoxide redical by the 
riboflavin and light system. Inhibitors of other reactive oxygen species such 
as catalase (for H 20 2 ) and mannitol, DMSO (for *OH) showed only marginal 
inhibition in absorbance at 560 nm (Table 2). 
Modification of Calf Thymus DNA by Superoxide 
Radical 
Native calf thymus DNA obtained commercia l ly was purified free of 
proteins, RNA and single stranded regions . A mixture of purified DNA and 
riboflavin in 10 mM Na-phosphate buffer, pH 8.0 was illuminated for 20 
min. at room temperature. The modified samples were dialyzed against 10 
mM Na-phosphate buffer to remove r iboflavin and Triton X-100. 
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CONCENTRATION OF SCAVENGERS 
Quenching of supe rox ide anion radical genera t ion by reactive 
oxygen species scavengers , SOD ( O ), boi led SOD 
( A ),catalase ( © ), mannitol ( # ) and D M S O ( V )• 
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TABLE 2 
Inhibition of Superoxide Radical Production by Various 
Reactive Oxygen Species Scavengers 
Inhibitors Absorbance Percent 
at 560 nm inhibition 
Control (Riboflavin + Triton X-100 + EDTA) 1.65 
Control + Superoxide dismutase (SOD) 0.40 75.8 
Control + Boiled SOD 1.61 2.4 
Control + Catalase 1.43 13.3 
Control + Mannitol 1.37 17.0 
Control + Dimethylsulphoxide (DMSO) 1.45 12.1 
The concentration of inhibitors used were, SOD (10 ug/ml), catalase (10 ug/ml), 
mannitol (10 mM) and DMSO (10 mM). Superoxide dismutase was inactivated 
by incubation in a boiling water bath for 60 min. 
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Characterization of Modified DNA 
Figure 6 shows the UV absorption spectra of superoxide radical 
modified DNA with characterist ic hyperchromicity at 260 nm. The percent 
hyperchromicity was 26% in 20 min illuminated sample. 
The modifications incurred on nDNA was also analyzed by UV-
difference spectroscopy. As depicted in figure 7, the spectral curve of 
superoxide modified DNA with respect to native DNA exhibited a 
remarkable hypochromic effect at 260 nm. Furthermore, the spectral curves 
exhibited a change in the maxima and minima to the extent of 15 nm 
and 10 nm respectively, for modified DNA relative to native DNA. The 
maxima for native DNA was observed at 260 nm which shifted to 275 nm 
in case of modified DNA. Similarly the minima of native DNA at 230 nm 
got shifted to 240 nm. 
Circu la r Dichroism of Native and Superoxide 
Modified DNA 
The circular dichroic spectra of the native and 02" modified DNA 
showed characteristic changes in the ellipticity. In this study, native DNA 
showed a negative peak at 244 nm and a positive peak at 276 nm with 
a shoulder around 280 nm. Superoxide modified DNA when compared with 
native DNA showed negative peak at 246 nm with change in ellipticity from 
-1.6 mdeg to -2.2 mdeg and a positive peak at 280 nm with change in 
ellipticity from 1.5 mdeg to 2.0 mdeg followed by a complete reversion 
of shoulder at 270 nm (Fig. 8). The result showed 25% increase in ellipticity 
of native DNA after superoxide radical modification. 
Thermal Melting of Superoxide Modified DNA 
Thermally induced transitions were measured spectrophotometrically at 
260 nm by heating nucleic acid samples at a rate of 1.5CC per min. Melting 
curves were recorded at temperatures from 30°C to 95°C. Increase in UV 
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6. Ul t raviole t absorption spectra of na t ive and superoxide modified 
calf t hymus DNA. nDNA ( ), superoxide modified DNA 
( ), r iboflavin + Triton X-100 ( ). 
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7. Ultraviolet difference spectroscopical scanning of native and 
superoxide modified DNA. nDNA with reference to PBS, pH 7.4 
( ), 0 2 -DNA with reference to nDNA ( ). 
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Fig . 8. Circular dichroic spec t ra of native DNA ( -) and O, -DNA 
62 
absorption at 260 nm was taken as a measure of denaturat ion. Figure 9 
shows the thermal denatura t ion profile of native and superoxide modified 
DNA. The melting tempera ture of native DNA at which 50% of the double 
helical structure is lost was found to be 87°C, while in case of superoxide 
modified DNA it was found to be 82.5°C. The results exhibit a net decreasu 
o f 4.5°C in the Tm value for the modified DNA when compared to its 
unmodified native conformer. These findings indicate, therefore, that the 
decrease in Tm to the extent of 4.5°C is primarily due to structural 
alterations of DNA which occurs upon generation of single strand breaks. 
The percent hyperchromicity and the values of native and modified DNA 
are shown in Table 3. 
Hydroxyapatite Column Chromatography 
Nucleic acids with different secondary structures have more affinity 
for hydroxyapatite than flexible, disordered polymers. Fractionation of 
nucleic acid samples was carried out on the basis of this property of 
hydroxyapatite. 
Calf thymus DNA samples ( 0 2 " modified and unmodif ied) in 10 mM 
Na-K-phosphate buffer, pH 6.8, were applied to hydroxyapat i te column, 
equilibrated with the same buffer. After washing the unbound material, 
stepwise elution was carr ied out using 125 mM and 250 mM Na-K-
phosphate buffer, pH 6.8. The chromatogram obtained with native DNA 
showed only one peak centered at 250 mM Na-K-phosphate buffer 
(Fig. 10a). The elution profi le of superoxide modified DNA showed a minor 
peak eluting with 125 mM buffer while a major fraction eluted with 250 
mM buffer (Fig. 10b). The minor fraction may be at tr ibuted to the 
generation of single s trand breaks. 
Nuclease S, Digestibility of Superoxide Modified DNA 
Native and superoxide modified calf thymus DNA were digested with 
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Fig. 9. Thermal melting profile of na t ive DNA ( 0 ) and O, -DNA 
( A ). 
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T A B L E 3 
Ultraviolet and Thermal Denaturation Characteristics of Native 
and Superoxide Modified DNA Under Identical Experimental 
Conditions 
Parameter Native DNA Q / - P N A 
Absorbance ratio (A260/A280) 
Percent hyperchromicity at 95°C 
Melting temperature (Tm), °C 
Onset of duplex melting, °C 
1.8 
37.0 
87.0 
82.0 
1.5 
29.7 
82.5 
35.0 
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Fig. 10. Hydroxyapa t i t e column chromatography of (a) native DNA and 
(b) Q. - -DNA. 
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nuclease S, (20 units/jig DNA) for 30 min. The residual DNA was detected 
by agarose gel electrophoresis. The controls were the unmodified DNA 
samples with and without nuclease S, t reatment . The result showed 
enhanced electrophoret ic mobility of S, nuclease digested modified DNA 
as compared to native DNA and native DNA treated with S, nuclease, 
showed almost identical electrophoretic migration pattern and fluorescence 
intensity (Fig. 11). 
Alkaline Sucrose Density Gradient Ultracentrifugation 
Superoxide modified and native DNA samples were subjected to 
sucrose density gradient ultracentrifugation under alkaline conditions to 
detect single strand breaks. Samples were denatured by the addition of 0.2 
N NaOH, transferred to top of 5-20% linear alkal ine sucrose gradient and 
sedimented at 30,000 rpm for one hour. The bottom of the tubes were 
pierced, fractions collected, monitored at 260 nm and data plotted as 
absorbance at 260 nm against fraction number. Figure 12 shows the 
sedimentation profile of native and superoxide modified DNA. Change in 
molecular weight of DNA due to single strand breaks by superoxide anion 
radicals can be observed as a change in the sedimentation rate. Native DNA 
banded as a sharp symmetrical peak, while superoxide modified DNA 
showed a diffused sedimentation profile indicat ing the generation of single 
strand breaks. 
Modification of Nitrogenous Bases in DNA by Superoxide 
Anion 
In order to separate the modified bases , superoxide modified DNA 
solution was subjected to acid hydrolysis. The neutralized hydrolyzate was 
applied to a DEAE Sephadex A-25 column and eluted with a linear gradient 
of 1-20 mM Tris-HCl buffer, pH 7.6. Control experiments were carried out 
by passing individual bases (Fig. 13) and hydrolyzed native DNA (Fig. 14). 
The elution profile of native DNA was similar to that obtained with 
b7 
1 1 5 4 
Fig. 11. Nuclease S, d iges t ib i l i ty of native and 0 , ' - D N A . Lane 1 
contained na t ive DNA, while lane 2 contained n D N A treated with 
nuclease S . Lane 3 contained 02""-DNA, whi le lane 4 contained 
02 ' -DNA t rea ted with nuclease S, for 30 min . Electrophoresis 
was carried ou t on 1% agarose gel for 2 hr at 30 mA. 
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ig. 12. Alkaline suc rose density gradient u l t racentr i fugat ion of native 
DNA ( O ) and 0 2 -DNA ( A )• 
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Fig. 13. Elution profile of standard individual DNA bases on DEAE Sephadex 
A-25 column, (a) Cytosine, (b) thymine, (c) adenine and (d) 
guanine. 
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14. Elution profile of acid hydro lyzed native DNA on DEAE Sephadex 
A-25 column. Peaks 1, 2, 3 and 4 represent cytosine, t hymine , 
adenine and guanine, respect ively . 
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individual bases. Peaks 1, 2, 3 and 4 represent cytosine, thymine , adenine 
and guanine respectively. 
The 02*-modified DNA showed the formation of additional base 
products (Fig. 15), separated on a DEAE Sephadex A-25 column after 
acid hydrolysis. The products were identified by comparison of the 
chromatographic patterns with standard bases. The first peak collected from 
the column represents cytos ine . The second and the third peaks correspond 
to modified and unmodifed thymine respectively. Adenine also eluted as two 
peaks (4 and 5). The last two peaks (6 and 7) were modified and unmodified 
guanine respectively. The extent of modification was determined by 
measuring the peak area of the modified and corresponding unmodified 
control. It was found that thymine was modified to a greater extent 
(51.8%), followed by guanine (40.5%) and adenine (22.2%) (Table 4). 
Antigenicity of Superoxide Modified DNA 
The antigenicity of the superoxide radical modified DNA was probed 
by inducing antibodies in rabbi ts . The antigenic specificity of the induced 
antibodies was assayed by direct binding and compet i t ion ELISA. The 
binding of these ant ibodies to the immunogen and native DNA was further 
substantiated by band shift assay. 
(a) Antibodies against superoxide modified DNA 
The antibodies raised against superoxide modified DNA was found to 
be n o n - p r e c i p i t a t i n g as observed by i m m u n o d i f f u s i o n and 
counter immunoelectrophoresis . Direct binding ELISA was used to 
characterize the immune response in rabbits following immunizat ion with 
0 2 modified DNA. The anti-serum showed a titre of 1:12800 (Fig. 16). 
The antibodies against nat ive DNA complexed with methyla ted BSA and 
adjuvant were also raised in rabbits. The results evaluated by direct binding 
ELISA showed negligible binding (Fig. 17). Preimmune serum as control 
did not show appreciable binding with the immunogen. 
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Fig. 15. Fractionation of acid hydrolyzed 0 2 -DNA on DEAE Sephadex A-
25 column. Peak 1 represen ts unmodified cytos ine , peaks 2 and 3 
represent modified and unmodified thymine, peaks 4 and 5 represent 
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TABLE 4 
Modification of Bases in DNA Exposed to Superoxide Anion 
Radicals 
Base Percent Modification 
Cytosine 
Adenine 22.2 
Thymine 51.8 
Guanine 40.5 
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Fig. 16. Direct binding ELISA of 0 2 ' - D N A with preimmune ( A ) and 
immune sera ( • ). The microt i t re plates were coated with 
0 , - D N A (2.5 jig/ml). 
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Fig. 17. Direct binding ELISA of nDNA and adjuvant with preimmune 
( O ) and immune sera against nDNA ( A ) and adjuvant 
( A )• 
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The specifici ty of the induced ant ibodies for antigenic determinants on 
modified DNA was evaluated by compet i t ive binding assays. A maximum 
of 7 1 % inhibi t ion in antibody binding was recorded at an inhibitor (Oy'-
DNA) concentra t ion of 20 ug/ml (Fig. 18). The concentration of the 
compet i tor required for 50% inhibit ion was 5.5 ug/ml. 
(b) Purification and binding characteristics of immune IgG 
Immunoglobul in G was isolated from preimmune and immune rabbit 
serum by affinity chromatography on Protein A-Sepharose CL-4B column 
(Fig. 19). The purity of the IgG was evaluated by SDS-polyacrylamide gel 
e lec t rophores is in absence of a reducing agent. The purified IgG migrated 
as a s ingle band upon electrophoresis (Fig. 19inset). 
Direct binding ELISA of the purified IgG showed a strong reactivity 
with the immunogen (Fig. 20). Preimmune IgG as negative control showed 
negl igible binding to modified DNA. 
(c) Antigenic specificity of anti-02"* DNA antibodies 
The ani t -Oy ' DNA antibodies exhibited a broad spectrum of reactivity 
as demonst ra ted by inhibiton assay using the immunogen, nucleic acids, 
synthetic polynucleotides and bases as inhibi tors . A maximum of 79 .3% 
inhibit ion of anti-02"' DNA IgG with immunogen as an inhibitor was 
observed (Fig. 21). Fifty percent inhibi t ion was achieved at an inhibitor 
concentrat ion of 0.2 ug/ml. Competi t ion experiments with native DNA 
showed considerable inhibition in ant ibody activity. Pre-incubation of 
immune ant ibody with native DNA inhibited its binding to modified DNA 
by 5 1 % at 20 ug/ml (Fig. 21), whereas, 50% inhibition was obtained at 
15 ug/ml of DNA. ROS-DNA, heat denatured DNA and 200 bp DNA showed 
a maximum inhibition of 49%, 5 1 % and 20% respectively at 20 ug/ml 
(Fig. 21) . Total RNA from buffalo thymus, mitochondrial DNA (mtDNA) 
and its ROS modified form showed moderate inhibitions of 44%, 26%, 6 1 % 
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Fig. 19. E lu t ion profile of ant i -0 2 ' -DNA IgG on Protein A-Sepharose CL-
4B column. Inset: SDS-PAGE of purified IgG on 7.5% 
ac ry lamide gel. 
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Fig. 2 0 . Direct binding ELISA of p r e i m m u n e ( A ) and immune IgG ( A ) 
with 02*-DNA. The microt i t re p la tes were coated with O, -DNA 
(2.5 ug/ml). 
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Fig. 21 . Inhibition of ant i -O, ' -DNA IgG binding to 0 2 -DNA. The 
competitors were 0 ; '-DNA ( O ), nDNA ( A ). ROS-DNA 
( A ), 200 bp DNA ( # ) and ssDNA ( v )• The microti tre 
plates were coated with 0 2 -DNA (2.5 ug/ml) . 
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and 47% respectively (Fig . 22) . 
Guanine, thymine, po ly (dT) and their ROS modified forms were used 
as inhibitors of antibody ac t iv i ty . Native guanine and thymine were non-
inhibitory showing inh ib i t ions of 27% and 19% respect ively (Fig. 23), 
whereas, ROS-guanine and ROS-thymine showed a maximum inhibition of 
40% and 25%. In contras t , poly(dT) and ROS-poly(dT) were found to be 
potent inhibitors, showing maximum inhibitions of 56% and 65% 
respectively (Fig. 24). The amount of poly(dT) and ROS-poly(dT) required 
for 50% inhibition in an t ibody activity was 10 ug/ml and 6.5 ug/ml 
respectively. The r ibonucleo t ide polymer poly(G) and ROS-poly(G) was also 
used as inhibitors. Poly(G) showed an inhibition of 49%, while ROS-poly(G) 
inhibited antibody binding to antigen to an extent of 54% (Fig. 25) 
To further define the structural de te rminan ts recognized by 
anti-Oy'DNA ant ibodies , thei r interactions with various synthet ic polymers 
were studied. Poly(dG-dC).poly(dG-dC) showed maximum inhibition of 
34% at a concentration of 20 ug/ml, whereas, poly(dA-dG).poly(dC-dT) and 
poly(dI-dC).poly(dI-dC) showed maximum inhibi t ions of 47% and 40% 
respectively (Fig. 26) . Table 5 summarises the resul ts of the inhibition 
studies of the anti-Gy' DNA antibody with various inh ib i tors . Their relative 
affinities have also been computed. 
Band Shift Assay 
The visual detect ion of antigen-antibody interact ion was performed by 
band shift assay. Constant amounts of native and modified DNA were 
incubated with varying amount s of immune IgG for 2 hr at room temperature 
and overnight at 4°C. The resulting immune complexes were then 
electrophoresed on 1 % agarose for 2 hr at 30 mA. Figure 27b shows the 
binding of IgG to O, " DNA. As clearly evident, with an increase in the 
amount of IgG, there was an increase in the formation of high molecular 
weight immune complexes , which resulted in re tarded mobility. The 
82 
_l I I L- I I I -1 I I I I I I 
- 1 I I I ' ' ' ' 
0.01 0.1 10 100 
INHIBITOR CONCENTRATION ( jug/ml) 
Fig. 22. Inhibition of anti-O, -DNA IgG binding to O/ '-DNA. The 
competitors were RNA ( Q ). ROS-RNA ( A ), mtDNA ( 4 ) 
and ROS-mtDNA ( # ). The microtitre p la tes were coated with 
(V-DNA (2.5 Mg/ml). 
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Fig . 2 3 . Inhibition of a n t i - O . ' - D N A IgG binding to O, -DNA. The 
competitors were g u a n i n e ( O ), ROS-guanine ( A ), thymine 
( A ) and ROS-thymine ( # ). The microtitre p la tes were coated 
with O/'-DNA (2.5 u g / m l ) . 
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24. Inhib i t ion of anti-02"-DNA IgG binding to 0 2 --DNA. The 
compet i to r s were poly(dT) ( Q ) and ROS-poly(dT) ( A ). The 
micro t i t re plates were coated wi th 0 , -DNA (2.5 ng/ml). 
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Fig. 25. Inhibition of ant i-Oy'-DNA IgG binding to Gy'-DNA. The 
competitors were poly(G) ( O ) and ROS-poly(G) ( A ). The 
microtitre plates were coated with 0 \ -DNA (2.5 jig/ml). 
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26. Inhibition of an t i -O, -DNA IgG binding to 0 , ' - D N A . The 
competitors were poly(dA-dG).poly(dC-dT) ( O ), poly(dG-
dC).poly(dG-dC) ( A ) and poly(dI-dC).po!y(dI-dC) ( A )• The 
microtitre plates were coated with 0 2 -DNA (2.5 n g ' m l ) . 
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TABLE 5 
Antigenic Specificity of Anti-Superoxide Radical Modified Calf 
Thymus DNA 
Inhibitor M 
at 
0 / -DNA 
nDNA 
ROS-DNA 
200 bp DNA 
RNA 
ROS-RNA 
ssDNA 
mtDNA 
ROS-mtDNA 
Native poly(G) 
ROS-poly(G) 
Guanine 
ROS-guanine 
Thymine 
ROS-thymine 
Poly(dT) 
ROS-poly(dT) 
Poly(dI-dC).poly(dI-dC) 
Poly(dG-dC).poly(dG-dC) 
Poly(dA-dG).poly(dC-dT) 
aximum % 
inhibition 
20 ug/ml 
79.3 
51.0 
49.0 
20.0 
44.0 
61.0 
51.3 
26.0 
47.0 
49.0 
54.0 
27.0 
40.0 
19.0 
25.0 
56.0 
65.0 
40.0 
34.0 
47.0 
Concentration for 
50% inhibition 
(ug/ml) 
0.2 
15.0 
-
-
-
15.0 
18.2 
-
-
-
13.8 
-
-
-
-
10.0 
6.5 
-
-
-
Percent relative 
affinity 
100.0 
1.3 
-
-
-
1.3 
1.0 
-
-
-
1.4 
-
-
-
-
2.0 
3.0 
-
-
-
Plates were coated with Gy'-DNA (2.5 ug/ml) 
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Fig. 27. Band shift assay of anti-02"-DNA IgG binding to (a) nDNA and 
(b) Oy ' -DNA. Native and 0 , " - D N A (1 ug each) were incubated 
with 30, 40, 50 and 60 ug IgG for 2 hr at 37°C and overnight 
at 4°C. Electrophoresis was per formed on 1% agarose for 2 hr 
at 30 mA. Lane 1, contained na t ive and modified DNA. Lanes 
2, 3 , 4 and 5 contained native and modified DNA with increasing 
concen t ra t ions of IgG. 
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recognition of native DNA by ant i -0 2 DNA IgG was re i tera ted by the shift 
in electrophoretic mobili ty upon immune complex formation (Fig. 27a). 
Characterization of Human Anti-DNA Autoantibodies 
Sera from twelve pat ients with systemic lupus erythematosus having 
antibodies with preference for native DNA were tested for its binding to 
superoxide modified DNA. The SLE anti-DNA autoant ibodies were found 
to be precipitating as detected by immunodiffusion (Fig. 28) and 
counterimmunoelectrophoresis (Fig. 29). The resul ts showed anti-DNA 
antibody titres of (1:1600 to 1:6400) (Figs. 30-32). SLE serum samples 
tested were further employed for the binding with 02*'-modified DNA. 
Reactivity of SLE Sera with Native and 02"* Modified 
DNA 
The binding pattern of serum antibodies to superoxide-modif ied DNA 
and native DNA from 12 patients with SLE was determined by direct binding 
ELISA. The results of direct binding assay of these SLE sera revealed a 
stronger binding to 0 2 -DNA (Table 6) except for 2 sera which showed 
almost equal binding to native and modifed DNA. 
The specificity of SLE autoantibodies was determined by competition 
experiments in which binding of the SLE sera to nat ive and 0 2 ' -DNA was 
assayed. Native DNA showed inhibitions of more than 50% in 8 sera with 
a maximum inhibition upto 68% in one serum at an inhib i tor concentration 
of 20 ug/ml (Figs. 33-38) . Superoxide-modified DNA on the other hand 
showed greater inhibit ion than native DNA with all 12 sera. The results 
indicated that 0 2 - m o d i f i e d DNA is the preferred ant igen compared to 
native DNA for SLE autoant ibodies . The inhibition data of native and 
O,'-modified DNA to SLE autoantibodies are shown in Tables 7 and 8. 
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Fig. 28. Ouchterlony immunodiffusion of SLE sera with (a) native DNA 
and (b) O, -DNA. 
91 
(GO 
Cb) 
Fig. 29. Counterimmunoelectrophoresis of (a) native DNA and (b) 
0 2 - D N A . 
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Fig. 30. Binding of SLE anti-DNA autoantibodies to native DNA. Curves 
( A ). ( A ), ( O ) and ( # ) represent different SLE sera 
and normal human serum ( V ) . The mic ro t i t r e plates were coated 
with nDNA (2.5 ug/ml). 
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Fig. 31 . Binding of SLE anti-DNA autoantibodies to native DNA. Curves 
( • ), ( A ), ( O ) and ( 0 ) represent different SLE sera 
and ( V ) represents normal human serum. The microtitre plates 
were coated with nDNA (2.5 ug/ml). 
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1.50 
-LOG SERUM DILUTION 
Binding of SLE anti-DNA autoantibodies to native DNA. Curves 
( A ), ( A )> ( O ) and ( # ) represent different SLE sera 
and ( V ) represents normal human serum. The microti tre plates 
were coated with nDNA (2.5 ug/ml). 
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TABLE 6 
Direct Binding ELISA of SLE Sera With Native and 
Superoxide-Modified DNA 
Sera No. Titre Absorbance at 410 nm 
Native DNA O, -DNA 
1 1:3200 
2 >1:3200 
3 <1:1600 
4 <1:1600 
5 1:6400 
6 1:6400 
7 1:3200 
8 <1:3200 
9 1:6400 
10 1:6400 
11 <1:3200 
12 <1:3200 
0.62 
0.58 
0.65 
0.82 
1.24 
0.71 
0.89 
0.96 
0.82 
1.38 
0.72 
0.76 
0.87 
0.83 
0.74 
0.92 
1.66 
1.20 
1.00 
1.17 
1.00 
1.66 
1.05 
1.01 
Sera at a dilution of 1:100 was employed. 
96 
' . I • I _ J ' i i • i i — i — i — i i i i 11 1 1 — i — i — i i 11 
01 0.1 1 10 100 
INHIBITOR CONCENTRATION ( jug/ml) 
33. Inhibition of SLE anti-DNA autoantibodies b ind ing to native 
DNA by nDNA and O, -DNA. Curves ( C ), ( A ) represent 
2 SLE sera with nDNA as inhibitor and ( • ) , ( # ) the same 
sera with 0 2 ' - D N A as inhibitor. The microti tre p la t e s were 
coated with nDNA (2.5 ng/ml). 
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Fig. 34. Inh ib i t i on of SLE anti-DNA au toan t ibod ies binding by nDNA and 
O / ' - D N A . Curves ( O ), ( A ) represen t 2 SLE sera with nDNA 
as inh ib i to r and ( A ), ( • ) with O/ ' -DNA as inhibitor. The 
mic ro t i t r e plates were coated with nDNA (2.5 ng/ml). 
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35. Innibition of SLE anti-DNA autoantibodies binding by nDNA and 
0 , - -DNA. Curves ( O ), ( A ) represent 2 SLE sera with nDNA 
as inhibitor and ( A ), ( • ) with O, -DNA as inhibitor. The 
microti tre plates were coated with nDNA (2.5 ng/ml). 
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Fig. 36. Inhibition of SLE anti-DNA autoantibodies b ind ing by nDNA and 
02--DNA. C u r v e s ( O ), ( A ) represent 2 SLE sera with nDNA 
as inhibitor and ( A ). ( • ) w»th 0 , ' - D N A as inhibitor. The 
microtitre p l a t e s were coated with nDNA (2.5 ug /ml ) . 
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Fig. 37. Inhibit ion of SLE anti-DNA autoant ibodies binding by nDNA and 
O, -DNA. Curves ( O ), ( A ) represent 2 SLE sera with nDNA 
as inhibitor and ( ± ), ( • ) with 0,"-DNA as inhibitor. The 
microt i t re plates were coated with nDNA (2.5 ug 'ml) . 
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Fig. 38. Inhibi t ion of SLE anti-DNA autoant ibodies binding by nDNA and 
O, -DNA. Curves ( O ), ( A ) represent 2 SLE sera with nDNA 
as inhibi tor and ( A )> ( • ) w i t h 0 , " - D N A as inhibitor. The 
microt i t re plates were coated with nDNA (2.5 ug/ml). 
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TABLE 7 
Inhibition of SLE Autoantibody Binding by Native DNA 
Sera No. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
Maximum percent 
inhibition at 
(20 ug/ml) 
56.0 
52.0 
55.0 
60.0 
50.0 
44.0 
41.0 
42.0 
49.0 
68.0 
45.0 
52.0 
Inhibitor concentration 
required for 50% 
inhibition (ug/ml) 
12.5 
6.0 
13.7 
16.2 
20.0 
-
-
-
-
11.0 
-
10.0 
The microtitre plate was coated with nDNA (2.5 ug/ml). 
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TABLE 8 
Inhibition of SLE Autoantibody Binding by 0 2 -DNA 
Sera No. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
Maximum percent 
inhibition at 
(20 ug/ml) 
65.0 
61.0 
66.0 
74.0 
65.0 
52.0 
52.0 
57.0 
60.0 
80.0 
60.0 
75.0 
Inhibitor concentration 
required for 50% 
inhibition (ug/ml) 
8.0 
0.6 
15.0 
6.5 
12.5 
15.0 
19.0 
15.0 
10.0 
4.5 
14.0 
0.6 
The microtitre plate was coated with nDNA (2.5 ug/ml). 
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Purification of SLE and Cancer Sera IgG 
SLE and cancer sera IgG were purified by affinity chromatography on 
Protein A-Sepharose CL-4B. Protein A has been known to bind IgG from 
most of the mammalian species. The purified IgG eluted in a single 
symmetrical peak (Fig. 39). Its purity was checked by SDS-PAGE under 
non-reducing condi t ions which resulted in a single band (Fig. 39 inset). 
Band Shift Assay 
Band shift assay was employed to confirm and visualize the interaction 
of native and 0 2 " -DNA with SLE autoant ibodies . A constant amount of 
antigen was incubated with varying amounts of SLE IgG for 2 hr at 37°C 
and overnight at 4°C. These immune complexes were then electrophoresed 
on 1% agarose for 2 hr at 30 mA. An increase in the IgG concentration 
caused an increase in the immune complex formation which resulted in a 
relative increase in the molecular weight and consequently retarded mobility 
(Fig. 40). 
Quantitative Precipitin Titration 
The ant igen-ant ibody interaction was also characterized by quantitative 
precipitin t i t ra t ion. Varying amounts of native and Gy -modified DNA were 
mixed with 100 ug of SLE IgG and incubated for 2 hr at 37°C and 72 
hr at 4°C. The resul ts obtained were typical of precipitin titration curve 
(Figs. 41 and 42) . Maximum antibody binding occurred at an antigen 
concentratin of 30 ug in case of native DNA and 25 ug for Oy'-DNA. 
Protein analysis of immune complexes showed that 66 ug of SLE IgG was 
bound to nat ive DNA, whereas, 79 ug of SLE IgG was bound to O, -
DNA. The affinity constant of anti-native DNA antibodies was evaluated 
by Langmuir analys is (Fig. 43) and apparent associat ion constant of native 
and Oy-DNA was computed to be 1 .19xl0 7 M and 2 . 7 4 x l 0 8 M respectively. 
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Fig. 39. Elution prof i le of SLE ( O ) and cance r IgG ( A ) o n Protein 
A-Sepharose CL-4B column. Inset : Pu r i ty of (a) isolated SLE 
IgG and (b) cancer IgG on 7.5% S D S - P A G E . 
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40. Band shift assay of SLE anti-DNA autoantibodies IgG binding 
to (a) nDNA and (b) O, -DNA. Native and 0 2 -DNA (1 ng each) 
were incubated with 20, 40, 60 and 80 ug IgG for 2 hr at 37°C 
and overnight at 4°C. Electrophoresis was performed on 1% 
agarose for 2 hr at 30 mA. Lane 1, contained native and modified 
DNA. Lanes 2, 3, 4 and 5 contained native and modified DNA 
with increasing concentrations of SLE IgG. 
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Fig. 4 1 . Quantitative precipitin t i t ra t ion curves of native DNA with 
normal human IgG ( A ) and SLE IgG ( A )• 
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Fig. 42. Quant i ta t ive precipitin ti tration curves of 0 2 '-DNA with normal 
human IgG ( A ) and SLE IgG ( A )• 
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43. Determination of antibody affinity for nDNA ( # ) and 02 -DNA 
( • ) by Langmuir plot. 
110 
Recognition of Antibodies from Cancer Sera 
The binding of native and 02"-modified DNA to cancer sera was 
evaluated using modified DNA as antigen in a competi t ive assay. The study 
comprised 27 sera from patients suffering from cancer of different organ 
and organ sys tems. Sera from normal, heal thy individuals served as control 
(Fig. 44). Cancer sera were obtained after careful clinical examination of 
patients with histopathological diagnosis a t tending J.N. Medical College 
Hospital, A.M.U. , Aligarh. 
The sample contained four sera of breast cancer. Out of these, three 
sera showed recogni t ion of modified DNA to a greater extent than native 
DNA. The maximum inhibition observed was 52%, 53% and 55%, while one 
sera showed moderate recognition with O,"-DNA (Fig. 45). The results 
indicated higher binding of antibodies in breast cancer sera towards 
superoxide-modified DNA than native DNA. 
Three sera (two male and one female) were collected from patients 
with cancer of urinary bladder. All three sera showed higher reactivity 
(44%, 47% and 41%) with modified DNA over native DNA (Fig. 46). Five 
sera (four female and one male) were from pat ients suffering from cancer 
of the gall bladder . Out of these, only one sera showed 50% inhibition 
with modified DNA, whereas, with native DNA all five sera showed 
inhibition below 50% (Fig. 47). 
Among three sera from lung cancer (one female and two male), two 
sera showed a higher inhibition of 61.6% and 69% with 0 2 -modified DNA 
while one sera showed a moderate inhibi t ion of 37% (Fig.48). 
Three sera were collected from pat ients suffering from carcinoma with 
secondaries l iver. Among the three sera, one showed 58.2% inhibition with 
modified DNA and another showed almost equal percent inhibition (42% 
and 43%) with native and modified DNA (Fig. 49). 
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Fig. 44. Detection of an t ibodies against native and O, -DNA in normal 
healthy i n d i v i d u a l s . Sera ( O )> ( A ) v-ith nDNA as inhibitor 
and ( A ). ( # ) with 02"-DNA as i nh ib i t o r . The microtitre 
plates were coa ted 0 2 -DNA (2.5 fig n l ) . 
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Detect ion of antibodies against nat ive and 0 2 '-DNA in the sera 
of pa t i en t s with breast cancer. The mic ro t i t r e plates were coated 
with 0 2 -DNA (2.5 ng/ml). The inh ib i to r s were nDNA (a) and 
0 , ' - D N A (b) . The curves ( O ) . ( A ), ( A. ) and ( # ) 
represent sera from different pa t ien ts . 
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Detect ion of antibodies against na t ive and 0 2 "-DNA in the sera 
of patients with urinary b ladder cancer . The microtitre p la t e s 
were coated with 0 , ' -DNA (2.5 ng /ml) . The inhibitors were 
nDNA (a) and 0 , -DNA (b) . The curves ( O ). ( A ) and 
( A ) represent sera from different pat ients . The microtitre p l a t e s 
were coated 0 : -DNA (2.5 j ig /ml ) . 
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Fig. 47. Detection of antibodies against native and O, '-DNA in the sera 
of pat ients with gall bladder cancer. The microt i t re plates were 
coated with 0 2 -DNA (2.5 ug/ml). The inhibi tors were nDNA (a) 
and 0 , - - D N A (b) . The curves ( O ) , ( A ) , ( 1 ) , 
( f ) and ( V ) represent sera from different patients. The 
microti tre p la tes were coated O, ' -DNA (2.5 ^g/ml) . 
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Fig. 48. Detection of antibodies against native and O/ ' -DNA in the sera 
of patients with lung cancer. The microtitre plates were coated 
with 0 / - D N A (2.5 ug/ml). The inhibitors were nDNA (a) and 
0 2 -DNA (b). The curves ( O ), ( A ) and ( A ) represent 
sera from different pat ients . The microtitre plates were coated 
0 / - D N A (2.5 ug/ml). 
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Fig. 49 . Detection of antibodies aga ins t native and 0, ' ' -DNA in the sera 
of patients with hepatocel lu lar carcinoma. The microt i t re p la tes 
were coated with 0, '"-DNA (2.5 ug/ml). The inhibi tors were 
nDNA (a) and 0 ,"-DNA ( b ) . The curves ( O ), ( A ) and 
( A ) represent sera from different patients. The microt i t re p la tes 
were coated 0 2 -DNA (2.5 ug/ml) . 
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Among four sera from prostate cancer, one was found positive for 
modified DNA with maximum inhibition of 36% and one with native DNA 
with maximum inhibition of 31%. The other sera showed reactivity with 
both modified and native DNA, with one having greater preference for 
modified DNA and another showing preference for native DNA (Fig. 
50). 
One serum sample each from Hodgkin ' s lymphoma and renal carcinoma 
showed higher recognition for 0 2 - D N A with maximum inhibitions of 69% 
and 57% respect ively (Fig. 50). One serum sample from caecum carcinoma 
showed high recognition for native DNA with maximum inhibition of 36.2% 
as compared to 0 2 -DNA (32%) (Fig. 51) . 
One serum sample each from stomach and rectum cancer were negative 
showing l i t t le recognition for native and modified DNA (Fig. 52). The 
binding data of cancer sera are shown in Table 9. 
Detection of Immune Complexes Deposition in Kidney 
02" -DNA and native DNA were injected in rats and immune response 
was screened by direct binding ELISA (Fig. 53). The immunofluorescence 
of the k idney sections revealed the deposi t ion of immune complexes in the 
glomeruli of kidney (Fig. 54a). Kidney section of rats immunized with native 
DNA served as control and did not show any fluorescence, suggesting the 
absence of immune complex deposition (Fig. 54b). 
Band Shift Assay 
The binding of native and modifed DNA to breast cancer IgG was 
detected by band shift assay. Constant amounts of antigen were incubated 
with varying amounts of cancer IgG for 2 hr at room temperature and 
overnight at 4°C. The immune complexes were then electrophoresed on 1% 
agarose for 2 hr at 30 mA. Figure 55b shows the higher binding of cancer 
IgG to modified DNA as compared to nat ive DNA (Fig. 55a) judged by 
their f luorescence intensity. 
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Detec t ion of antibodies against nat ive and 0 2 -DNA in the sera 
of pa t i en t s with prostate cancer . The microtitre plates were 
coated with 0 2 -DNA (2.5 j ig/ml) . The inhibitors were nDNA (a) 
and 0 2 -DNA (b). The curves ( O ). ( A ), ( A ) and ( # ) 
represen t sera from different pa t ien t s . The microtitre plates were 
coated O, -DNA (2.5 ng/ml) . 
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Detection of an t i bod i e s against native and 0 , ' " -DNA in the sera 
of patients with H o d g k i n ' s lymphoma, renal and caecal cancer. 
The microtitre p l a t e s were coated with O, -DNA (2.5 ug/ml). The 
inhibitors were nDNA (a) and 0 2 -DNA (b). The curves ( O ). 
( A ) and ( A ) represent sera from renal, caecal cancer and 
Hodgkin's lymphoma pat ients , respectively. The microt i t re plates 
were coated O, -DNA (2.5 ug/ml). 
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Detection of antibodies against native and 02 "-DNA in the sera 
of patients with stomach and rectal cancer. The microtitre plates 
were coated with 02"*-DNA (2.5 u.g/ml). The inhibitors were 
(a) nDNA and (b) Oz -DNA. The curves ( O ) and 
( A ) represent sera from stomach and rectal cancer respectively. 
The microtitre plates were coated O -DNA (2.5 ng/ml). 
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TABLE 9 
Inhibition of Circulating Antibodies in Cancer sera with Native 
and 02 -Modified DNA 
Type of Cancer No. of 
sera tested 
Maximum percent Maximum percent 
inhibition by inhibition by 
nDNA at (20 ug/ml) CyDNA at (20 ug/ml) 
Breast 33, 12, 49, 19 52, 53, 55, 25 
Urinary bladder 30, 33, 29 44, 47, 41 
Gall bladder 20, 30, 23, 32, 14 40, 50, 48, 37, 46 
Lung 
Hepatocellular 
Prostate 
Hodgkin's lymphoma 
Renal 
Caecum 
Stomach 
Rectal 
3 
3 
4 
56, 
19, 
22, 
50 
34 
36 
22 
11 
57, 
29, 
20, 
43 
42 
31, 24 
62, 69, 37 
39, 58, 43 
36, 23, 8, 26 
69 
57 
32 
26 
28 
Microtitre plates were coated with O -DNA (2.5 ug/ml). 
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Fig. 53. Binding of 0 , ' - D N A with preimmune ( A ) and immune sera ( ± ) 
of rats. The mic ro t i t r e plate was coated with O, ' -DNA (2.5 ug/ml). 
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Fig. 54. Detection of immune complexe(s) deposition in the kidney sections 
of rats immunized wi th (a) nDNA and (b) 0," '-DNA. The immune 
ccmplexe(s) d e p o s i t i o n were observed under f luorescent 
microscope. 
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Fig. 55. Band shift assay of breast cancer IgG binding to (a) nDNA and (b) 
O, -DNA. Nat ive and 0 2 -DNA (1 ug each) were incubated with 
20, 40, 60 and 80 ug IgG for 2 hr at 37°C and overnight at 4°C. 
E lec t rophores i s was performed on 1% agarose for 2 hr at 30 mA. 
Lane 1, con t a ined native and modified DNA. Lanes 2, 3, 4 and 5 
contained nat ive and modified DNA with increasing concentrations 
of breast cancer IgG. 
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It is well established that aerobic organisms constantly produce small amounts 
of reactive oxygen species (ROS) (Fridovich, 1989). There has been considerable 
interest on the damaging effect of ROS, like superoxide radical (02"), hydrogen 
peroxide and hydroxyl radical (Fridovich, 1986; Halliwell, 1987; Ballmer et al, 
1994) on nucleic acid, proteins and lipids. These radicals modify DNA at various 
sites that include base damage (Dizdaroglu et al, 1991) leading to mutations 
(Moody and Hassan, 1982; Brawn and Fridovich, 1985) may activate proto-
oncogenes and act as promoters of carcinogenesis (Cerutti, 1985; Crawford et al, 
1988; Weitzman et al., 1985; Halliwell and Gutteridge, 1989; Ohshima and Bartsch, 
1994; Clayson et al., 1994; Ames et al., 1995). Cellular DNA is damaged by oxygen 
free radicals generated during cellular respiration, cell injury, phagocytosis and 
exposure to environmental oxidants (Floyd et al., 1986; Fridovich, 1986; Kasai 
et al., 1986; Klebanoff, 1988; Breimer, 1990). The most striking evidence 
implicating 02" in the production of DNA damage in vivo has been obtained with 
E. coli strains lacking cytosolic SOD. These strains are hypermutagenic when 
grown in air-saturated media, suggesting that an increase in 0 2 leads to an increase 
in DNA damage (Farr et al, 1986). 
Among these radicals, superoxide is the most abundant reactive species 
generated in vivo by several enzymatic and non-enzymatic pathways in mammalian 
tissue (Fridovich, 1986; Devasagayam et al, 1991; Sies and Menck, 1992; ). 
Though it has been implicated in several disease states and unfavourable alteration 
of tissues and biomolecules (McCord, 1985; Cross, 1987; Epe et al, 1988), its 
ability to induce damage to DNA directly has been questioned. The damaging effect 
observed in the presence of 0 2 ' has been postulated to result from the highly 
reactive hydroxyl radical which is generated when 0 2 ' reacts with transition metal 
ions and not due to superoxide per se (Halliwell, 1988). This study shows that 
the single strand breaks observed by illumination of riboflavin system in a metal 
free solution is due to 0 2 ' itself. Furthermore, superoxide dismutase, a specific 
inhibitor of 02"\ and not the boiled enzyme, almost completely inhibited DNA 
damage and the scavenger of hydroxyl radical does not have any significant effect. 
The above facts clearly established that O "* is truly capable of inducing single 
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strand breaks. It has been demonstrated that 0 2 * itself can exert deleterious effect 
in biological systems (Fridovich, 1986). 
Systemic lupus erythematosus is a multisystem, immune complex disease of 
unknown etiology, characterized by the presence of anti-DNA autoantibodies of 
multiple specificities to numerous self components which includes nuclear and 
cytoplasmic antigens (Tan, 1989; Pisetsky, 1994). The marked heterogeneity of 
SLE autoantibodies has been one of the impediments in understanding the disease. 
The immune abnormalities contributing to the development of systemic autoimmune 
diseases in mice and humans are now being defined at the single cell and molecular 
levels. There have been many theories proposed to explain the origin of 
autoimmune responses. It has been suggested that while neither exogenous 
polyclonal B or T cell activators nor immunoregulatory disturbances appear to 
be satisfactory explanations, it is clear that development of overt autoimmune 
disease is highly dependent on a permissive genetic constitution (Theofilopoulos, 
1995). 
Antibodies to DNA in SLE have been extensively studied and may be specific 
for ssDNA, reactive with both ssDNA and dsDNA, or specific for dsDNA (Stollar, 
1979; Worrall et al., 1990; ). It is the antibodies to native dsDNA that represent 
a characteristic serological finding in these patients and one of important diagnostic 
and clinical value. They are thought to be highly specific for this disease, 
particularly when renal complications are present (Aitcheson and Tan, 1982). 
The binding diversity of lupus autoantibodies to a whole spectrum of modified 
nucleic acid conformers (Ali et al., 1991; Alam and AH, 1992; Alam et al., 1992; 
1993; Arjumand and Ali, 1994; Arif et al., 1994; Klinman et al, 1994; Moinuddin 
and Ali, 1994; Arjumand et al., 1995) seems to be enormous. The studies to 
understand the origin and consequence of anti-ds-DNA antibodies are still in 
progress. For these reasons, it was thought desirable to investigate the 
immunogenicity of superoxide modified calf thymus DNA and its possible role in 
SLE and development of cancer. 
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Cancer, the biological consequence with the most complex etiology, has been 
implicated in free radical induced damage to DNA (Ames et a/.. 1993a; 1995). 
Despite enzymatic repair and other defenses, continuous ROS damage and division 
of cells with unrepaired and misrepaired lesions lead to mutations. If these relate 
to critical genes such as oncogenes or tumor suppressor genes initiation and/or 
progression of cancer can occur. 
In the present study, native calf thymus DNA was modified by superoxide 
anion radicals generated by illumination of riboflavin. The generation of superoxide 
radicals was confirmed by quenching with superoxide dismutase (SOD), the specific 
enzyme which dismutates 0 2 ' (Sies and Menck, 1992). Almost complete inhibition 
of superoxide generation by SOD and lack of similar effect by heat denatured 
SOD indicates that the effect is not due to physical quenching of radical by protein 
component of the enzyme, but due to its enzymatic activity of scavenging 02"\ 
Inhibitors (catalase, mannitol, DMSO) of other reactive oxygen species show only 
marginal decrease in superoxide radical production. Single strand breaks were 
observed in DNA in an incubation medium treated with a metal chelating agent, 
thereby, avoiding the possible creation of the highly reactive hydroxyl radical, 
convincingly showed that strand breaks induced by this system is truely due to 
superoxide radical. 
The photochemical reaction of riboflavin with DNA resulted in an increase 
in absorption at 260 nm, this could be attributed to single strand breaks and 
modification of bases. The chemically predominant reaction was breakage of sugar 
phosphate backbone. 
The UV difference spectral curves exhibited appreciable perturbation in 
native DNA as a consequence of photochemical modification. The spectral curves 
of 02""-modified DNA exhibited a remarkable hypochromic effect at 260 nm and 
change in Xmax and Xmin. These are indicative for an appreciable proportion of 
superoxide induced damage of both bases, as well as sugar-phosphate backbone. 
The CD spectra of native DNA consist of a positive and negative band of 
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nearly equal magnitude with intersection point at the absorption maximum, a 
characteristic feature of B-DNA. The increase in ellipticity and slight change 
in peaks of DNA after 02"' modification may be due to unstacking of bases as 
a result of single strand breaks. 
The thermal denaturation profile of native and 02"-DNA showed a net 
decrease of 4.5°C in the Tm value for modified DNA as compared to its unmodified 
native conformer. This is primarily due to the presence of single stranded regions 
in the modified DNA, and partial destruction in its secondary structure. Base 
stacking as well as hydrogen bonding are involved in stabilizing the native structure 
of DNA and their disruption by high temperature favours denaturation (Casperson 
and Voss, 1983; Thomas, 1993). The earlier reports of decrease in melting 
temperature further substantiate the generation of single strand breaks on 
illumination of DNA in the presence of riboflavin (Speck et al., 1976). 
The formation of single stranded regions was studied by hydroxyapatite 
column chromatography which discriminates nucleic acids endowed with different 
secondary structures, with rigid, ordered structures having more affinity for the 
matrix than flexible, disordered ones (Bernardi, 1965; 1969). Native DNA eluted 
as single peak with 250 mM Na-K phosphate buffer, indicating their double 
strandedness. In contrast, 0 2 "-DNA eluted as two peaks - one minor and one major. 
The minor peak eluted at lower ionic strength of 125 mM Na-K phosphate buffer. 
The minor peak may be attributed to the generation of single stranded regions 
in DNA after illumination in presence of riboflavin. 
Earlier studies demonstrate the structural alteration in DNA following damage 
by various agents and may be large enough to be recognised by single strand 
specific nucleases (Kato and Fraser, 1973; Slor and Lev, 1973; Shisido and Ando, 
1974; Yamasaki et al., 1977). When native and 0 2 "-DNA were subjected to 
nuclease S, digestion, the single stranded regions in modified DNA were selectively 
removed as seen by the enhanced electrophoretic mobility, whereas, nDNA 
remained undigested. 
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The presence of single strand regions in DNA following modification with 
superoxide anion radical was further ascertained by alkaline sucrose density 
gradient centrifugation. The sedimentation profile of 0 2 -DNA was distinct from 
that of nDNA, which banded as a sharp symmetrical peak, In contrast, the modified 
DNA appeared as a broader peak indicating the generation of single strand breaks 
which causes decrease in the molecular weight and hence the diffused pattern. 
The data are compatible with earlier reports implicating superoxide radicals in 
strand breakage (Speck et al., 1976). 
In addition to the alteration within sugar-phosphate backbone, superoxide 
radical was also found to modify DNA bases. DNA treated with superoxide 
radicals showed that thymine was modified maximally (51.8%) followed by guanine 
(40.5%). These results are consistent with earlier studies which demonstrate greater 
susceptibility of thymine and guanine to modification by reactive oxygen species 
(Demple and Lin, 1982; Hutchinson, 1985; Yamamoto and Kawanishi, 1989; Rosen 
et al, 1996). 
Although most nucleic acids are considered to be immunogenic, dsDNA of 
the B-conformation is not (Madaio et al., 1984; Stollar, 1986). Some synthetic 
homopolynucleotides, chemically modified DNA, helical synthetic polynucleotides 
and denatured DNA are immunogenic. Effective helical immunogen inducing 
antibodies in this form have been double-stranded RNA, RNA-DNA hybrid, left 
handed Z-DNA, triple helical RNA and DNA analogues and double helical 
polydeoxynbonucleotides, DNA modified with drugs, hormones, chromatin or DNA 
in complexes with DNA binding proteins (Stollar, 1973; 1975; 1986; Anderson 
et al., 1988a; Desai et al., 1993; Moinuddin and Ali, 1994; Hasan et al., 1995; 
Arif and Ali, 1996; Arjumand, et al., 1995; 1997; Theofilopoulous, 1995). 
Reactive oxygen species modified DNA have been implicated in the pathogenesis 
of SLE and cancer (Ara and Ali, 1993; 1995; Du et al, 1994; Ahmad et al., 
1997) Cooke et al., 1997). Conformational variance from the B-form appears to 
be a prerequisite for the induction of an antibody response (Burlingame et al, 
1993; Mohan et al., 1993), although the reason for this is unclear (Braun and 
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Lee, 1988). 
Antibodies against superoxide modified calf thymus DNA were induced in 
rabbits by immunizing with 0 2 *-DNA complexed with methylated bovine serum 
albumin. The superoxide modified DNA was a potent immunizing stimulus, inducing 
high titre antibodies. These results are consistent with earlier studies that 
treatement of dsDNA with the superoxide generating system xanthine-xanthine 
oxidase transforms DNA into an immunogenic state (Jansson, 1985). Specificity 
of purified anti-Gy'-DNA IgG was assessed by competition ELISA. A maximum 
of 79.3% inhibition was observed with the immunogen. The concentration of 
immunogen required for 50% inhibition of IgG binding to immunogen was observed 
to be 0.2 ug/ml. In addition, the induced antibodies showed considerable binding 
to native DNA. This cross-reactivity may be due to the recognition of an antigenic 
determinant common to both 0 2 ' -DNA and nDNA and could possibly be the sugar-
phosphate backbone (Lafer et al., 1981; Rauch et al., 1985; Lee et al., 1985). 
ROS-DNA, ssDNA and 200 bp DNA showed inhibitions of 49%, 51% and 20% 
respectively. The data indicates that the binding of IgG towards ssDNA may be 
due to the opening of helix of DNA after denaturation which helps in higher 
recognition by IgG. Buffalo thymus RNA and mitochondrial DNA (mtDNA) 
showed 44% and 26% inhibitions, whereas, their ROS-modified forms showed 
higher inhibitions of 61% and 47% respectively. These results indicate the increased 
recognition of free radical modified DNA by the induced anti-02 "-DNA antibodies. 
Competition immunoassay using guanine, thymine, poly(dT) showed 
inhibitions of 27%, 19% and 56%, respectively. In contrast, ROS-guanine, ROS-
thymine and ROS-poly(dT) showed higher inhibition (40%, 25% and 65%) of 
IgG binding to immunogen. The data clearly indicates that the immune IgG is more 
specific to guanine, thymine and poly(dT) after ROS-modification. Earlier reports 
demonstrated guanine and thymine moiety to be particularly susceptible to ROS 
modification (Hutchinson, 1985; Lunec et al., 1994; Breen and Murphy, 1995). 
To further define the structural determinant recognized by the anti-0 *-DNA 
antibodies, their interaction with various synthetic polynucleotides was studied. 
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These compounds present a limited set of determinants than natural DNA and can 
be used as probe for specificity analysis. Poly(dG-dC).poly(dG-dC), poly (dA-
dG).poly(dC-dT) which are stable as B-DNA at low salt concentration, inhibited 
the antibody binding. However, 50% inhibition could not be achieved. The broad 
recognition of the induced antibodies with a variety of polynucleotides might be 
due to the recognition of the phosphodiester-backbone (Ballard and Voss, 1982; 
Shoenfeld et al, 1983; Rauch et al., 1985). 
Systemic lupus erythematosus (SLE) is a highly variegated and pleomorphic 
autoimmune disease (Andrzejewski et al., 1980) of unknown etiology. Sera of SLE 
patients contain a variety of autoantibodies of which a subset may be responsible 
for the array of chemical symptoms (Chastagner et al., 1994). Antibodies to dsDNA 
serve as an immunochemical marker for the diagnosis of SLE. However, native 
DNA is a poor immunogen and rarely induces antibodies in experimental animals. 
It has been reported that DNA after exposure to ROS presents a more 
discriminating antigen for the binding of SLE autoantibodies (Blount et al., 1989; 
1990; Ara and Ali, 1992; 1993; Cooke et al., 1997). The detection of 8-
hydroxyguanosine in the immune complex derived DNA of SLE (Lunec et al., 1994) 
reinforces the evidence that ROS may be involved in SLE. Thus, it appears that 
ROS-modification exposes epitopes on DNA that are recognized by circulating anti-
DNA antibodies in SLE sera. 
In the present study, anti-DNA antibodies from twelve different SLE sera 
showed considerable binding to Cy'-DNA except two sera which showed almost 
equal binding to native and 02" DNA. No antibody activity was found in normal 
human sera. Competition ELISA results showed 4 1 % to 68% inhibition in the anti-
DNA autoantibody binding to native DNA, whereas, 52% to 80% inhibition was 
observed with Oy'-DNA as competitor. These results indicate that the modified 
DNA is an effective inhibitor, showing substantial difference in the recognition 
of Cy'-DNA over native DNA. Band shift assay further substantiated the binding 
of native and Gy-modified DNA with SLE anti-DNA autoantibodies. 
The data of quantitative precipitin assay of anti-native DNA autoantibodies 
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in SLE sera with native and 0 2 -DNA was analyzed by Scatchard and Langmuir 
isotherm plots and antibody affinity was calculated. In case of 0 2 ' -DNA the 
apparent association constant was computed to be 2.7 x 10 8 M and for native 
DNA it was 1.1 x 107 M. The affinity constants clearly indicate that the 0 2 -
modified DNA has better recognition for SLE anti-DNA autoantibodies as 
compared to native DNA. The data obtained by various immunological techniques 
clearly demonstrates a substantial increas in recognition and binding of 02"-
modified DNA over nDNA by circulating anti-DNA autoantibodies. 
Increased levels of circulating antibodies and autoantibodies have been 
reported in sera of patients with malignancies (Tannenberg et al., 1973; 
Whitehouse, 1973; Wasserman et al., 1975; Anderson et al., 1988b; Chagnaud et 
al., 1992; Faiderbe et al., 1992; Becker et al., 1994). Attempts have been made 
to establish the molecular identity of the autoantigens that are targets of 
autoantibodies in cancer without much success. Elevated levels of anti-nuclear 
antibodies up to 27% in cancer have been reported (Bunham, 1972; Zeronski et 
al., 1972). The clinical significance of autoantibodies in cancer is unclear, although 
the presence of anti-nuclear antibodies might indicate a worse prognosis or a more 
frequent recurrence of breast cancer (Wasserman et al., 1975; Turnbull et al., 
1978). In patients with hepatocellular carcinoma, a high prevalence of anti-nuclear 
antibodies has been reported (Kiyosawa et al., 1985; Imai et al., 1992; 1993). 
In the present study, the presence of autoantibodies reactive towards native 
DNA and 02 -DNA in sera of patients with cancer was also studied. The study 
comprised of 27 sera from patients with various types of malignancies. 
Four sera from breast cancer showed higher recognition for O/'-DNA as 
compared to nDNA. It has been well accepted that ROS damage to DNA plays 
a fundamental role in carcinogenesis, particularly of breast cancer (Malins and 
Haimanot, 1991; Malins et al., 1996). Therefore, ROS modification of DNA might 
be the contributory factor in the induction of circulating autoantibodies primarily 
against 0 2 '-DNA but crossreacting with nDNA. Oxidative DNA damage resulting 
from active oxygen species has been hypothesized to play a critical role in several 
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biological processes including cancer and autoimmune diseases (Cerutti, 1985; 
Ames, 1989). It has been reported that human renal cell, lung and hepatocellular 
carcinoma are strongly correlated with oxidative DNA damage (Mc Bride et al., 
1991; Olinski et al., 1992; Okamoto et al., 1994). Tobacco smoke may be involve 
in mitochondrial production of ROS, which have the potential to cause DNA 
damage (Leanderson and Tagesson, 1990; 1992). Hence, oxidative DNA damage 
is postulated to be major event in the development of these cancers. Sera from 
lung cancer patients recognized 0 2 *-DNA to a greater extent. These patients have 
history of smoking and support for strong oxidative stress in vivo. Hepatocellular 
carcinoma is actively associated with chronic viral hepatitis B and C and this results 
in the generation of ROS due to the presence of inflammation (Cotran et al., 1989; 
Cerruti and Trump, 1991). Two sera from patients of hepatocellular carcinoma 
also had chronic hepatitis infection which could again explain the onset of cancer 
as described earlier (Beasley, 1988; Stein, 1991). 
Similarly, the results obtained with sera from cancer with urinary bladder, 
prostate and Hodgkin's lymphoma have more preference for 02 '-DNA as compared 
to nDNA. Further, the binding of native and 02~'-modified DNA with circulating 
cancer autoantibodies were substantiated by gel retardation assay. These results 
are indicative of the presence of 02~'induced DNA damage in cancer patients which 
might play an active part in the progression of disease mediated by mutation and 
subsequent neoplastic transformation of the cell. Presence of autoantibodies in 
cencer sera reactive towards 0 2 ' -DNA and nDNA may be attributed to 0 2 -
inducted DNA damage rendering it immunogenic. The autoantibodies may, 
therefore, be raised primarily against 0 2 -DNA and cross-react with nDNA. 
It has been suggested that both the site of immune deposit and the resulting 
pathologic and clinical abnormalities may be dependent on properties unique to 
a subset of anti-DNA autoantibodies (Raz et al, 1989; Vlhakos et al., 1992). 
Kidney sections from rats immunized with native and 02"-DNA were screened 
for immune complex deposition in glomerulus as evident by apple green colour 
only in case of modified DNA. This observation is consistent with the studies of 
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Koffler et al. (1974), which provided evidence for the deposition of immune 
complexes in glomeruli of SLE patients. 
Based on the above studies, the following conclusions can be drawn. 
1. Illumination of DNA in presence of riboflavin resulted in the formation of 
single strand breaks and DNA base modifications. 
2. Thymine was the major base modified with 0 2 " followed by guanine. 
3. Modified conformers are thermodynamically less stable as compared to native 
form. 
4. 02"-modified DNA is highly immunogenic in experimental animals. 
5. Induced antibodies are highly specific for immunogen and also show 
substantial cross-reactivity with nDNA. 
6. The induced antibodies show significant binding with various synthetic 
nucleic acid polymers. 
7. Anti-02 '-DNA antibodies recognize the ROS -modified conformers better than 
native conformers of the polynucleotides. 
8. The multiple binding characteristics of anti-O,"' antibodies towards various 
nucleic acids polymers resembles the binding characteristics of SLE anti-
DNA antibodies. 
9. SLE anti-DNA autoantibodies showed preferential binding for 02 '-DNA than 
nDNA. 
10. 02"-DNA presents a discriminating antigen for the binding of SLE 
autoantibodies. 
11. Rats immunized with native and 0 2 -DNA induce high titre antibodies. 
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12. Sera of various cancer patients recognize and bind 0 2 -DNA to greater extent 
as an antigen. 
13. Immune complex deposition in the glomeruli of kidney of rats immunized with 
02"- modified DNA was observed. 
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